| Year |
Citation |
Score |
| 2019 |
Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig T, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, ... ... Agid Y, et al. Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial. Parkinsonism & Related Disorders. PMID 31257096 DOI: 10.1016/J.Parkreldis.2019.05.023 |
0.361 |
|
| 2019 |
Lau B, Meier N, Serra G, Czernecki V, Schuepbach M, Navarro S, Cornu P, Grabli D, Agid Y, Vidailhet M, Karachi C, Welter ML. Axial symptoms predict mortality in patients with Parkinson disease with subthalamic stimulation. Neurology. PMID 31043471 DOI: 10.1212/Wnl.0000000000007562 |
0.395 |
|
| 2019 |
Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig T, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, ... ... Agid Y, et al. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology. PMID 30737338 DOI: 10.1212/Wnl.0000000000007037 |
0.362 |
|
| 2017 |
Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, et al. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial. The Lancet. Neurology. PMID 28645853 DOI: 10.1016/S1474-4422(17)30160-6 |
0.519 |
|
| 2014 |
Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, ... ... Agid Y, et al. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology. 82: 1352-61. PMID 24647024 DOI: 10.1212/Wnl.0000000000000315 |
0.581 |
|
| 2013 |
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, ... ... Agid Y, et al. Neurostimulation for Parkinson's disease with early motor complications. The New England Journal of Medicine. 368: 610-22. PMID 23406026 DOI: 10.1056/Nejmoa1205158 |
0.357 |
|
| 2012 |
Brun Y, Karachi C, Fernandez-Vidal S, Jodoin N, Grabli D, Bardinet E, Mallet L, Agid Y, Yelnik J, Welter ML. Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease. Journal of Neurophysiology. 108: 1575-83. PMID 22745463 DOI: 10.1152/Jn.00254.2012 |
0.586 |
|
| 2012 |
Welter M, Demain A, Westby M, Bonneville F, Do MC, Montcel STd, Dormont D, Agid Y, Fernandez-Vidal S, Chastan N. Higher Level Gait Disorders in the Elderly Subject: Postural Instability, Cortical and Subcortical Abnormalities (P06.077) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.077 |
0.339 |
|
| 2012 |
Welter M, Czernecki V, Schupbach M, Fernandez-Vidal S, Karachi C, Navarro S, Cornu P, Pidoux B, Mallet L, Dormont D, Vidailhet M, Grabli D, Bonnet A, Belaid H, Houeto J, ... ... Agid Y, et al. Why Does Bilateral Subthalamic Stimulation Induced Cognitive Decline in Patients with Parkinson's Disease? (IN6-2.001) Neurology. 78: IN6-2.001-IN6-2.001. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In6-2.001 |
0.552 |
|
| 2011 |
Dickson DW, Hauw JJ, Agid Y, Litvan I. Progressive Supranuclear Palsy and Corticobasal Degeneration Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders: Second Edition. 135-155. DOI: 10.1002/9781444341256.Ch15 |
0.344 |
|
| 2010 |
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nature Reviews. Neuroscience. 11: 760-72. PMID 20944662 DOI: 10.1038/Nrn2915 |
0.388 |
|
| 2010 |
Worbe Y, Mallet L, Golmard JL, Béhar C, Durif F, Jalenques I, Damier P, Derkinderen P, Pollak P, Anheim M, Broussolle E, Xie J, Mesnage V, Mondon K, Viallet F, ... ... Agid Y, et al. Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? Plos One. 5: e12959. PMID 20885982 DOI: 10.1371/Journal.Pone.0012959 |
0.464 |
|
| 2010 |
Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI, Quinn NP, Speelman JD, Benabid AL, Fraix V, Mendes A, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 578-86. PMID 20213817 DOI: 10.1002/Mds.22735 |
0.369 |
|
| 2010 |
Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y. Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 368-76. PMID 20063435 DOI: 10.1002/mds.22922 |
0.343 |
|
| 2010 |
Schüpbach WM, Corvol JC, Czernecki V, Djebara MB, Golmard JL, Agid Y, Hartmann A. Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 20-5. PMID 19622523 DOI: 10.1136/jnnp.2008.159699 |
0.36 |
|
| 2009 |
Ribeiro MJ, Thobois S, Lohmann E, du Montcel ST, Lesage S, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Broussolle E, Brice A, Remy P. A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1244-50. PMID 19617340 DOI: 10.2967/Jnumed.109.063529 |
0.54 |
|
| 2009 |
Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, Van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, ... ... Agid Y, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1154-61. PMID 19412954 DOI: 10.1002/Mds.22496 |
0.359 |
|
| 2009 |
Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Archives of Neurology. 66: 102-8. PMID 19139307 DOI: 10.1001/Archneurol.2008.555 |
0.332 |
|
| 2009 |
Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain : a Journal of Neurology. 132: 156-71. PMID 19029129 DOI: 10.1093/Brain/Awn291 |
0.347 |
|
| 2009 |
Chastan N, Westby GW, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease. Brain : a Journal of Neurology. 132: 172-84. PMID 19001482 DOI: 10.1093/brain/awn294 |
0.378 |
|
| 2009 |
Lohmann E, Thobois S, Lesage S, Broussolle E, du Montcel ST, Ribeiro MJ, Remy P, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Brice A. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology. 72: 110-6. PMID 18987353 DOI: 10.1212/01.Wnl.0000327098.86861.D4 |
0.579 |
|
| 2009 |
Bardinet E, Bhattacharjee M, Dormont D, Pidoux B, Malandain G, Schüpbach M, Ayache N, Cornu P, Agid Y, Yelnik J. A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. Journal of Neurosurgery. 110: 208-19. PMID 18976051 DOI: 10.3171/2008.3.17469 |
0.365 |
|
| 2009 |
Chastan N, Do MC, Bonneville F, Torny F, Bloch F, Westby GW, Dormont D, Agid Y, Welter ML. Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 188-95. PMID 18973252 DOI: 10.1002/mds.22269 |
0.375 |
|
| 2009 |
Payoux P, Remy P, Miloudi M, Houeto JL, Stadler C, Bejjani BP, Yelnik J, Samson Y, Rascol O, Agid Y, Damier P. Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 235-43. PMID 18781162 DOI: 10.1038/jcbfm.2008.107 |
0.35 |
|
| 2009 |
Lohmann E, Leclere L, De Anna F, Lesage S, Dubois B, Agid Y, Dürr A, Brice A. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. Parkinsonism & Related Disorders. 15: 273-6. PMID 18718805 DOI: 10.1016/J.Parkreldis.2008.06.008 |
0.34 |
|
| 2008 |
Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, du Montcel ST, Yelnik J, Chéreau I, Arbus C, Raoul S, Aouizerate B, Damier P, Chabardès S, Czernecki V, ... ... Agid Y, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. The New England Journal of Medicine. 359: 2121-34. PMID 19005196 DOI: 10.1056/Nejmoa0708514 |
0.515 |
|
| 2008 |
Welter ML, Mallet L, Houeto JL, Karachi C, Czernecki V, Cornu P, Navarro S, Pidoux B, Dormont D, Bardinet E, Yelnik J, Damier P, Agid Y. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Archives of Neurology. 65: 952-7. PMID 18625864 DOI: 10.1001/Archneur.65.7.952 |
0.542 |
|
| 2008 |
Czernecki V, Schüpbach M, Yaici S, Lévy R, Bardinet E, Yelnik J, Dubois B, Agid Y. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 964-9. PMID 18398913 DOI: 10.1002/mds.21949 |
0.387 |
|
| 2008 |
Bonneville F, Bloch F, Kurys E, du Montcel ST, Welter ML, Bonnet AM, Agid Y, Dormont D, Houeto JL. Camptocormia and Parkinson's disease: MR imaging. European Radiology. 18: 1710-9. PMID 18351343 DOI: 10.1007/s00330-008-0927-8 |
0.367 |
|
| 2008 |
Lohmann E, Welter ML, Fraix V, Krack P, Lesage S, Laine S, Tanguy ML, Houeto JL, Mesnage V, Pollak P, Durr A, Agid Y, Brice A. Are parkin patients particularly suited for deep-brain stimulation? Movement Disorders : Official Journal of the Movement Disorder Society. 23: 740-3. PMID 18228569 DOI: 10.1002/Mds.21903 |
0.36 |
|
| 2008 |
Blomstedt P, Hariz MI, Lees A, Silberstein P, Limousin P, Yelnik J, Agid Y. Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report. Parkinsonism & Related Disorders. 14: 253-6. PMID 17561432 DOI: 10.1016/j.parkreldis.2007.04.005 |
0.331 |
|
| 2008 |
Chastan N, Westby GWM, Yelnik J, Bardinet E, Do MC, Agid Y, Welter ML. P2.110 Stimulation of the subthalamic nucleus and substantia nigra: gait analysis in Parkinson's disease patients Parkinsonism & Related Disorders. 14. DOI: 10.1016/S1353-8020(08)70341-9 |
0.409 |
|
| 2007 |
Corvol JC, Anzouan-Kacou JB, Fauveau E, Bonnet AM, Lebrun-Vignes B, Girault C, Agid Y, Lechat P, Isnard R, Lacomblez L. Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis. Archives of Neurology. 64: 1721-6. PMID 18071034 DOI: 10.1001/archneur.64.12.1721 |
0.347 |
|
| 2007 |
Houeto JL, Yelnik J, Bardinet E, Vercueil L, Krystkowiak P, Mesnage V, Lagrange C, Dormont D, Le Bas JF, Pruvo JP, Tezenas du Moncel S, Pollak P, Agid Y, Destée A, Vidailhet M, et al. Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum. Archives of Neurology. 64: 1281-6. PMID 17846266 DOI: 10.1001/Archneur.64.9.1281 |
0.313 |
|
| 2007 |
Mallet L, Schüpbach M, N'Diaye K, Remy P, Bardinet E, Czernecki V, Welter ML, Pelissolo A, Ruberg M, Agid Y, Yelnik J. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proceedings of the National Academy of Sciences of the United States of America. 104: 10661-6. PMID 17556546 DOI: 10.1073/Pnas.0610849104 |
0.514 |
|
| 2007 |
Maltête D, Jodoin N, Karachi C, Houeto JL, Navarro S, Cornu P, Agid Y, Welter ML. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease. Journal of Neurophysiology. 97: 4017-22. PMID 17460099 DOI: 10.1152/jn.01104.2006 |
0.368 |
|
| 2007 |
Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A, et al. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Archives of Neurology. 64: 425-30. PMID 17353388 DOI: 10.1001/Archneur.64.3.425 |
0.336 |
|
| 2007 |
Schüpbach WM, Maltête D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Gargiulo M, Béhar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 68: 267-71. PMID 17151341 DOI: 10.1212/01.Wnl.0000250253.03919.Fb |
0.577 |
|
| 2007 |
Schüpbach MW, Welter ML, Bonnet AM, Elbaz A, Grossardt BR, Mesnage V, Houeto JL, Maltête D, Mallet L, Rocca WA, Mallet A, Agid Y. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 257-61. PMID 17149702 DOI: 10.1002/Mds.21264 |
0.556 |
|
| 2007 |
Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A. Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 119-22. PMID 17080443 DOI: 10.1002/Mds.21178 |
0.376 |
|
| 2007 |
Agid Y, Schüpbach M, Gargiulo M, Welter ML, Mallet L, Behar C, Houeto JL, Maltête D, Mesnage V. Reply from the authors [10] Neurology. 68: 1164-1165. DOI: 10.1212/01.wnl.0000261103.50365.5b |
0.359 |
|
| 2006 |
Sedel F, Ribeiro MJ, Remy P, Blau N, Saudubray JM, Agid Y. Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia. Neurology. 67: 2243-5. PMID 17190955 DOI: 10.1212/01.wnl.0000249335.35585.3e |
0.332 |
|
| 2006 |
Agid Y, Schüpbach M, Gargiulo M, Mallet L, Houeto JL, Behar C, Maltête D, Mesnage V, Welter ML. Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so? Journal of Neural Transmission. Supplementum. 409-14. PMID 17017560 DOI: 10.1007/978-3-211-45295-0_61 |
0.523 |
|
| 2006 |
Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommée E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1941-6. PMID 16972268 DOI: 10.1002/Mds.21098 |
0.528 |
|
| 2006 |
Houeto JL, Mallet L, Mesnage V, Tezenas du Montcel S, Béhar C, Gargiulo M, Torny F, Pelissolo A, Welter ML, Agid Y. Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Archives of Neurology. 63: 1090-5. PMID 16908734 DOI: 10.1001/Archneur.63.8.1090 |
0.557 |
|
| 2006 |
Schüpbach M, Gargiulo M, Welter ML, Mallet L, Béhar C, Houeto JL, Maltête D, Mesnage V, Agid Y. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology. 66: 1811-6. PMID 16801642 DOI: 10.1212/01.Wnl.0000234880.51322.16 |
0.554 |
|
| 2006 |
Bloch F, Houeto JL, Tezenas du Montcel S, Bonneville F, Etchepare F, Welter ML, Rivaud-Pechoux S, Hahn-Barma V, Maisonobe T, Behar C, Lazennec JY, Kurys E, Arnulf I, Bonnet AM, Agid Y. Parkinson's disease with camptocormia. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1223-8. PMID 16754693 DOI: 10.1136/jnnp.2006.087908 |
0.448 |
|
| 2006 |
Contarino MF, Welter ML, Agid Y, Hartmann A. Orthostatic tremor in monozygotic twins. Neurology. 66: 1600-1. PMID 16717234 DOI: 10.1212/01.wnl.0000216263.23642.db |
0.306 |
|
| 2006 |
Pillon B, Ardouin C, Dujardin K, Vittini P, Pelissolo A, Cottencin O, Vercueil L, Houeto JL, Krystkowiak P, Agid Y, Destée A, Pollak P, Vidailhet M. Preservation of cognitive function in dystonia treated by pallidal stimulation. Neurology. 66: 1556-8. PMID 16717218 DOI: 10.1212/01.Wnl.0000216131.41563.24 |
0.311 |
|
| 2006 |
Ibáñez P, Lesage S, Lohmann E, Thobois S, De Michele G, Borg M, Agid Y, Dürr A, Brice A. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain : a Journal of Neurology. 129: 686-94. PMID 16401616 DOI: 10.1093/Brain/Awl005 |
0.357 |
|
| 2006 |
Etchepare F, Rozenberg S, Mirault T, Bonnet AM, Lecorre C, Agid Y, Bourgeois P, Fautrel B. Back problems in Parkinson's disease: an underestimated problem. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 298-302. PMID 16376599 DOI: 10.1016/j.jbspin.2005.05.006 |
0.316 |
|
| 2005 |
Pessiglione M, Czernecki V, Pillon B, Dubois B, Schüpbach M, Agid Y, Tremblay L. An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution. Journal of Cognitive Neuroscience. 17: 1886-96. PMID 16356326 DOI: 10.1162/089892905775008661 |
0.338 |
|
| 2005 |
Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltête D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, ... Agid Y, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1640-4. PMID 16291886 DOI: 10.1136/Jnnp.2005.063206 |
0.58 |
|
| 2005 |
Lesage S, Ibanez P, Lohmann E, Pollak P, Tison F, Tazir M, Leutenegger AL, Guimaraes J, Bonnet AM, Agid Y, Dürr A, Brice A. G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Annals of Neurology. 58: 784-7. PMID 16240353 DOI: 10.1002/Ana.20636 |
0.339 |
|
| 2005 |
Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schöls L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wüllner U, et al. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Annals of Neurology. 58: 720-9. PMID 16193476 DOI: 10.1002/Ana.20628 |
0.306 |
|
| 2005 |
Houeto JL, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V, Welter ML, Navarro S, Pelissolo A, Damier P, Pidoux B, Dormont D, Cornu P, Agid Y. Tourette's syndrome and deep brain stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 992-5. PMID 15965209 DOI: 10.1136/Jnnp.2004.043273 |
0.542 |
|
| 2005 |
Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? Journal of Neurology, Neurosurgery, and Psychiatry. 76: 775-9. PMID 15897497 DOI: 10.1136/jnnp.2003.033258 |
0.381 |
|
| 2005 |
Bonneville F, Welter ML, Elie C, du Montcel ST, Hasboun D, Menuel C, Houeto JL, Bonnet AM, Mesnage V, Pidoux B, Navarro S, Cornu P, Agid Y, Dormont D. Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology. 64: 1598-604. PMID 15883323 DOI: 10.1212/01.WNL.0000160401.24880.83 |
0.373 |
|
| 2005 |
Gerlach M, Reichmann H, Riederer P, Olanow CW, Agid Y, Mizuno Y. Levodopa in the treatment of Parkinson's disease: Current controversies: Letter to the Editors Movement Disorders. 20: 643-643. PMID 15732130 DOI: 10.1002/Mds.20435 |
0.35 |
|
| 2005 |
Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tézenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. The New England Journal of Medicine. 352: 459-67. PMID 15689584 DOI: 10.1056/Nejmoa042187 |
0.314 |
|
| 2005 |
Gargiulo M, Schupbach M, Behar C, Welter ML, Maltete D, Houeto J-, Mallet L, Mesnage V, Pillon B, Pidoux B, Dormont D, Cornu P, Navarro S, Agid Y. Neurochirurgie de la maladie de Parkinson : conséquences psychologiques et familiales Revue Neurologique. 161: 9-10. DOI: 10.1016/S0035-3787(05)85003-9 |
0.494 |
|
| 2005 |
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, Yebenes JD, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, et al. Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004)) Movement Disorders. 20. DOI: 10.1002/Mds.20519 |
0.339 |
|
| 2005 |
Gargiulo M, Schupbach M, Behar C, Welter ML, Maltete D, Houeto JL, Mallet L, Mesnage V, Pillon B, Pidoux B, Dormont D, Cornu P, Navarro S, Agid Y. Neurosurgery of Parkinson's disease: Psychological and family consequences | Neurochirurgie de la maladie de Parkinson: Conséquences psychologiques et familiales Revue Neurologique. 161: 1S9-1S10. |
0.504 |
|
| 2004 |
Kreisler A, Stankoff B, Ribeiro MJ, Agid Y, Lubetzki C, Fontaine B. Unexpected aggravation of Parkinson's disease by a mesencephalic multiple sclerosis lesion. Journal of Neurology. 251: 1526-7. PMID 15645356 DOI: 10.1007/s00415-004-0570-5 |
0.359 |
|
| 2004 |
Ibáñez P, Bonnet AM, Débarges B, Lohmann E, Tison F, Pollak P, Agid Y, Dürr A, Brice A. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet. 364: 1169-71. PMID 15451225 DOI: 10.1016/S0140-6736(04)17104-3 |
0.372 |
|
| 2004 |
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, et al. Levodopa in the treatment of Parkinson's disease: current controversies. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 997-1005. PMID 15372588 DOI: 10.1002/Mds.20243 |
0.386 |
|
| 2004 |
Payoux P, Remy P, Damier P, Miloudi M, Loubinoux I, Pidoux B, Gaura V, Rascol O, Samson Y, Agid Y. Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of Neurology. 61: 1307-13. PMID 15313852 DOI: 10.1001/archneur.61.8.1307 |
0.313 |
|
| 2004 |
Mesnage V, Houeto JL, Bonnet AM, Clavier I, Arnulf I, Cattelin F, Le Fur G, Damier P, Welter ML, Agid Y. Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease. Clinical Neuropharmacology. 27: 108-10. PMID 15190231 DOI: 10.1097/00002826-200405000-00003 |
0.343 |
|
| 2004 |
Ibáñez P, Lohmann E, Pollak P, Durif F, Tranchant C, Agid Y, Dürr A, Brice A. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease. Neurology. 62: 2133-4. PMID 15184637 DOI: 10.1212/01.Wnl.0000127496.23198.75 |
0.352 |
|
| 2004 |
Maltête D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Archives of Neurology. 61: 390-2. PMID 15023817 DOI: 10.1001/archneur.61.3.390 |
0.382 |
|
| 2004 |
Le Ber I, Bouslam N, Rivaud-Péchoux S, Guimarães J, Benomar A, Chamayou C, Goizet C, Moreira MC, Klur S, Yahyaoui M, Agid Y, Koenig M, Stevanin G, Brice A, Dürr A. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain : a Journal of Neurology. 127: 759-67. PMID 14736755 DOI: 10.1093/Brain/Awh080 |
0.326 |
|
| 2004 |
Welter ML, Houeto JL, Bonnet AM, Bejjani PB, Mesnage V, Dormont D, Navarro S, Cornu P, Agid Y, Pidoux B. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Archives of Neurology. 61: 89-96. PMID 14732625 DOI: 10.1001/archneur.61.1.89 |
0.335 |
|
| 2004 |
Welter M-, Maltete D, Houeto J-, Schupbach M, Mallet L, Gargiulo M, Behar C, Bonnet A-, Mesnage V, Pidoux B, Dormont D, Cornu P, Navarro S, Agid Y. Faut-il opérer les patients parkinsoniens précocement ? Revue Neurologique. 160: 18-19. DOI: 10.1016/S0035-3787(04)70874-7 |
0.464 |
|
| 2003 |
Jarraya B, Bonnet AM, Duyckaerts C, Houeto JL, Cornu P, Hauw JJ, Agid Y. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1517-20. PMID 14673889 DOI: 10.1002/Mds.10607 |
0.39 |
|
| 2003 |
Ibáñez P, De Michele G, Bonifati V, Lohmann E, Thobois S, Pollak P, Agid Y, Heutink P, Dürr A, Brice A. Screening for DJ-1 mutations in early onset autosomal recessive parkinsonism. Neurology. 61: 1429-31. PMID 14638971 DOI: 10.1212/01.Wnl.0000094121.48373.Fd |
0.309 |
|
| 2003 |
Lücking CB, Chesneau V, Lohmann E, Verpillat P, Dulac C, Bonnet AM, Gasparini F, Agid Y, Dürr A, Brice A. Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. Archives of Neurology. 60: 1253-6. PMID 12975291 DOI: 10.1001/Archneur.60.9.1253 |
0.327 |
|
| 2003 |
Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. Journal of Neurochemistry. 86: 1142-8. PMID 12911622 DOI: 10.1046/J.1471-4159.2003.01923.X |
0.358 |
|
| 2003 |
Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM, Fraix V, Broussolle E, Horstink MW, Vidailhet M, Verpillat P, Gasser T, Nicholl D, Teive H, Raskin S, ... ... Agid Y, et al. How much phenotypic variation can be attributed to parkin genotype? Annals of Neurology. 54: 176-85. PMID 12891670 DOI: 10.1002/Ana.10613 |
0.321 |
|
| 2003 |
Waubant E, Tezenas du Montcel S, Jedynak C, Obadia M, Hosseini H, Damier P, Lubetzki C, Agid Y, Degos JD. Multiple sclerosis tremor and the Stewart-Holmes manoeuvre. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 948-52. PMID 12889088 DOI: 10.1002/mds.10454 |
0.306 |
|
| 2003 |
Yelnik J, Damier P, Demeret S, Gervais D, Bardinet E, Bejjani BP, François C, Houeto JL, Arnule I, Dormont D, Galanaud D, Pidoux B, Cornu P, Agid Y. Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. Journal of Neurosurgery. 99: 89-99. PMID 12854749 DOI: 10.3171/jns.2003.99.1.0089 |
0.335 |
|
| 2003 |
Pessiglione M, Guehl D, Agid Y, Hirsch EC, Féger J, Tremblay L. Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease. Brain : a Journal of Neurology. 126: 1392-408. PMID 12764060 DOI: 10.1093/Brain/Awg139 |
0.334 |
|
| 2003 |
Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S, Teive H, Fraix V, Vidailhet M, Nicholl D, Barone P, Wood NW, Raskin S, Deleuze JF, Agid Y, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain : a Journal of Neurology. 126: 1271-8. PMID 12764050 DOI: 10.1093/Brain/Awg136 |
0.333 |
|
| 2003 |
Thobois S, Ribeiro MJ, Lohmann E, Dürr A, Pollak P, Rascol O, Guillouet S, Chapoy E, Costes N, Agid Y, Remy P, Brice A, Broussolle E. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study. Archives of Neurology. 60: 713-8. PMID 12756135 DOI: 10.1001/Archneur.60.5.713 |
0.334 |
|
| 2003 |
Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Archives of Neurology. 60: 690-4. PMID 12756132 DOI: 10.1001/archneur.60.5.690 |
0.369 |
|
| 2003 |
Linazasoro G, Houeto JL, Mesnage V, Mallet L, Welter ML, Dormont D, Pidoux B, Cornu P, Agid Y. Subthalamic deep brain stimulation for advanced Parkinson's disease: All that glitters is not gold [8] Journal of Neurology Neurosurgery and Psychiatry. 74: 827. PMID 12754372 DOI: 10.1136/jnnp.74.6.827 |
0.515 |
|
| 2003 |
Merino-Andreu M, Arnulf I, Konofal E, Derenne JP, Agid Y. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology. 60: 1553-4. PMID 12743258 DOI: 10.1212/01.Wnl.0000058905.71369.97 |
0.31 |
|
| 2003 |
Rawal N, Periquet M, Lohmann E, Lücking CB, Teive HA, Ambrosio G, Raskin S, Lincoln S, Hattori N, Guimaraes J, Horstink MW, Dos Santos Bele W, Brousolle E, Destée A, Mizuno Y, ... ... Agid Y, et al. New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology. 60: 1378-81. PMID 12707451 DOI: 10.1212/01.Wnl.0000056167.89221.Be |
0.326 |
|
| 2003 |
Olanow CW, Schapira AH, Agid Y. Neuroprotection for Parkinson's disease: prospects and promises. Annals of Neurology. 53: S1-2. PMID 12666093 DOI: 10.1002/ana.10566 |
0.383 |
|
| 2003 |
Houeto JL, Mesnage V, Welter ML, Mallet L, Agid Y, Bejjani BP. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology. 60: 154-5; author reply . PMID 12530402 |
0.512 |
|
| 2003 |
Lang AE, Kleiner-Fisman G, Saint-Cyr JA, Miyasaki J, Lozano A, Houeto JL, Mesnage V, Welter ML, Mallet L, Agid Y, Bejjani BP, Berney A, Ghika J, Villemure JG, Vingerhoets FJG. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up [3] (multiple letters) Neurology. 60: 154-155. PMID 12525751 |
0.511 |
|
| 2003 |
Agid Y, Olanow W, Mizuno Y. Dopamine agonists for Parkinson's disease The Lancet. 361: 84. DOI: 10.1016/S0140-6736(03)12149-6 |
0.39 |
|
| 2002 |
Mesnage V, Houeto JL, Welter ML, Agid Y, Pidoux B, Dormont D, Cornu P. Parkinson's disease: neurosurgery at an earlier stage? Journal of Neurology, Neurosurgery, and Psychiatry. 73: 778-9. PMID 12438494 DOI: 10.1136/jnnp.73.6.778 |
0.413 |
|
| 2002 |
Bejjani BP, Houeto JL, Hariz M, Yelnik J, Mesnage V, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y. Aggressive behavior induced by intraoperative stimulation in the triangle of Sano. Neurology. 59: 1425-7. PMID 12427896 DOI: 10.1212/01.Wnl.0000031428.31861.23 |
0.304 |
|
| 2002 |
Rawal N, Periquet M, Dürr A, de Michele G, Bonifati V, Teive HA, Raskin S, Guimaraes J, Agid Y, Brice A. Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease. Journal of Neurology. 249: 1127-9. PMID 12420720 DOI: 10.1007/S00415-002-0757-6 |
0.366 |
|
| 2002 |
Mallet L, Mesnage V, Houeto JL, Pelissolo A, Yelnik J, Behar C, Gargiulo M, Welter ML, Bonnet AM, Pillon B, Cornu P, Dormont D, Pidoux B, Allilaire JF, Agid Y. Compulsions, Parkinson's disease, and stimulation. Lancet. 360: 1302-4. PMID 12414208 DOI: 10.1016/S0140-6736(02)11339-0 |
0.578 |
|
| 2002 |
Agid Y, Olanow CW, Mizuno Y. Levodopa: why the controversy? Lancet. 360: 575. PMID 12241695 DOI: 10.1016/S0140-6736(02)09733-7 |
0.309 |
|
| 2002 |
Douhou A, Debeir T, Murer MG, Do L, Dufour N, Blanchard V, Moussaoui S, Bohme GA, Agid Y, Raisman-Vozari R. Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice. Experimental Neurology. 176: 247-53. PMID 12093102 DOI: 10.1006/exnr.2002.7935 |
0.334 |
|
| 2002 |
Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y. Behavioural disorders, Parkinson's disease and subthalamic stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 72: 701-7. PMID 12023409 DOI: 10.1136/Jnnp.72.6.701 |
0.523 |
|
| 2002 |
Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y. Parkinson's disease and sleepiness: an integral part of PD. Neurology. 58: 1019-24. PMID 11940685 DOI: 10.1212/Wnl.58.7.1019 |
0.304 |
|
| 2002 |
Gourfinkel-An I, Vila M, Faucheux B, Duyckaerts C, Viallet F, Hauw JJ, Brice A, Agid Y, Hirsch EC. Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA. Journal of Neurochemistry. 80: 466-76. PMID 11905993 DOI: 10.1046/J.0022-3042.2001.00734.X |
0.391 |
|
| 2002 |
Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain : a Journal of Neurology. 125: 575-83. PMID 11872614 DOI: 10.1093/Brain/Awf050 |
0.425 |
|
| 2002 |
Hartmann A, Mouatt-Prigent A, Faucheux BA, Agid Y, Hirsch EC. FADD: A link between TNF family receptors and caspases in Parkinson's disease. Neurology. 58: 308-10. PMID 11805265 DOI: 10.1212/Wnl.58.2.308 |
0.363 |
|
| 2002 |
Michel PP, Agid Y. Chronic Activation of the Cyclic AMP Signaling Pathway Promotes Development and Long‐Term Survival of Mesencephalic Dopaminergic Neurons Journal of Neurochemistry. 67: 1633-1642. PMID 8858948 DOI: 10.1046/J.1471-4159.1996.67041633.X |
0.301 |
|
| 2001 |
Lehéricy S, Grand S, Pollak P, Poupon F, Le Bas JF, Limousin P, Jedynak P, Marsault C, Agid Y, Vidailhet M. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology. 57: 1055-66. PMID 11571334 DOI: 10.1212/Wnl.57.6.1055 |
0.302 |
|
| 2001 |
Bonifati V, De Michele G, Lücking CB, Dürr A, Fabrizio E, Ambrosio G, Vanacore N, De Mari M, Marconi R, Capus L, Breteler MM, Gasser T, Oostra B, Wood N, Agid Y, et al. The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 22: 51-2. PMID 11487197 DOI: 10.1007/S100720170042 |
0.381 |
|
| 2001 |
Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet AM, Descombes S, Bejjani B, Fabre N, Montastruc JL, Agid Y. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 708-13. PMID 11481696 DOI: 10.1002/Mds.1143 |
0.352 |
|
| 2001 |
Muriel MP, Agid Y, Hirsch E. Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 435-41. PMID 11391736 DOI: 10.1002/mds.1103 |
0.345 |
|
| 2001 |
Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 185-9. PMID 11295768 DOI: 10.1002/mds.1037 |
0.311 |
|
| 2001 |
Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 2247-55. PMID 11264300 DOI: 10.1523/Jneurosci.21-07-02247.2001 |
0.35 |
|
| 2001 |
Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? Journal of Neurochemistry. 76: 1785-93. PMID 11259496 DOI: 10.1046/j.1471-4159.2001.00160.x |
0.377 |
|
| 2001 |
Zarate-Lagunes M, Gu WJ, Blanchard V, Francois C, Muriel MP, Mouatt-Prigent A, Bonici B, Parent A, Hartmann A, Yelnik J, Boehme GA, Pradier L, Moussaoui S, Faucheux B, Raisman-Vozari R, ... Agid Y, et al. Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes. The Journal of Comparative Neurology. 432: 184-96. PMID 11241385 DOI: 10.1002/Cne.1096 |
0.407 |
|
| 2001 |
Brandel JP, Peoc'h K, Beaudry P, Welaratne A, Bottos C, Agid Y, Laplanche JL. 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients. Annals of Neurology. 49: 257-60. PMID 11220747 DOI: 10.1002/1531-8249(20010201)49:2<257::AID-ANA48>3.0.CO;2-X |
0.305 |
|
| 2000 |
Jan C, François C, Tandé D, Yelnik J, Tremblay L, Agid Y, Hirsch E. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. The European Journal of Neuroscience. 12: 4525-35. PMID 11122363 DOI: 10.1111/J.1460-9568.2000.01351.X |
0.319 |
|
| 2000 |
Cancel G, Duyckaerts C, Holmberg M, Zander C, Yvert G, Lebre AS, Ruberg M, Faucheux B, Agid Y, Hirsch E, Brice A. Distribution of ataxin-7 in normal human brain and retina. Brain : a Journal of Neurology. 123: 2519-30. PMID 11099453 DOI: 10.1093/Brain/123.12.2519 |
0.333 |
|
| 2000 |
Yelnik J, Damier P, Bejjani BP, Francois C, Gervais D, Dormont D, Arnulf I, M Bonnet A, Cornu P, Pidoux B, Agid Y. Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease. Neuroscience. 101: 77-87. PMID 11068138 DOI: 10.1016/S0306-4522(00)00364-X |
0.329 |
|
| 2000 |
Hirsch EC, Périer C, Orieux G, François C, Féger J, Yelnik J, Vila M, Levy R, Tolosa ES, Marin C, Trinidad Herrero M, Obeso JA, Agid Y. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends in Neurosciences. 23: S78-85. PMID 11052224 DOI: 10.1016/S1471-1931(00)00021-5 |
0.373 |
|
| 2000 |
Bejjani BP, Arnulf I, Vidailhet M, Pidoux B, Damier P, Papadopoulos S, Bonnet AM, Cornu P, Dormont D, Agid Y. Irregular jerky tremor, myoclonus, and thalamus: a study using low-frequency stimulation. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 919-24. PMID 11009200 DOI: 10.1002/1531-8257(200009)15:5<919::Aid-Mds1024>3.0.Co;2-0 |
0.333 |
|
| 2000 |
Dubus P, Faucheux B, Boissière F, Groppi A, Vital C, Vital A, Agid Y, Hirsch EC, Merlio JP. Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease. Experimental Neurology. 165: 285-94. PMID 10993689 DOI: 10.1006/exnr.2000.7447 |
0.354 |
|
| 2000 |
Houeto JL, Bejjani PB, Damier P, Staedler C, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y. Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology. 55: 728-30. PMID 10980748 DOI: 10.1212/Wnl.55.5.728 |
0.323 |
|
| 2000 |
Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, Bonnet AM, Pollak P, Benabid AL, Agid Y. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology. 55: 411-8. PMID 10932277 DOI: 10.1212/Wnl.55.3.411 |
0.362 |
|
| 2000 |
Ransmayr G, Faucheux B, Nowakowski C, Kubis N, Federspiel S, Kaufmann W, Henin D, Hauw JJ, Agid Y, Hirsch EC. Age-related changes of neuronal counts in the human pedunculopontine nucleus. Neuroscience Letters. 288: 195-8. PMID 10889341 DOI: 10.1016/S0304-3940(00)01244-1 |
0.322 |
|
| 2000 |
Lücking CB, Dürr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denèfle P, Wood NW, Agid Y, Brice A. Association between early-onset Parkinson's disease and mutations in the parkin gene. The New England Journal of Medicine. 342: 1560-7. PMID 10824074 DOI: 10.1056/NEJM200005253422103 |
0.368 |
|
| 2000 |
Zalla T, Sirigu A, Pillon B, Dubois B, Agid Y, Grafman J. How patients with Parkinson's disease retrieve and manage cognitive event knowledge. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 36: 163-79. PMID 10815704 DOI: 10.1016/S0010-9452(08)70522-7 |
0.371 |
|
| 2000 |
Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? Annals of Neurology. 47: 655-8. PMID 10805339 DOI: 10.1002/1531-8249(200005)47:5<655::Aid-Ana16>3.0.Co;2-# |
0.406 |
|
| 2000 |
Orieux G, Francois C, Féger J, Yelnik J, Vila M, Ruberg M, Agid Y, Hirsch EC. Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease. Neuroscience. 97: 79-88. PMID 10771341 DOI: 10.1016/S0306-4522(00)00011-7 |
0.348 |
|
| 2000 |
Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Archives of Neurology. 57: 461-5. PMID 10768618 DOI: 10.1001/Archneur.57.4.461 |
0.402 |
|
| 2000 |
Bejjani BP, Gervais D, Arnulf I, Papadopoulos S, Demeret S, Bonnet AM, Cornu P, Damier P, Agid Y. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 68: 595-600. PMID 10766889 DOI: 10.1136/Jnnp.68.5.595 |
0.39 |
|
| 2000 |
Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, Bonnet AM, Marsault C, Agid Y, Philippon J, Cornu P. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. Journal of Neurosurgery. 92: 615-25. PMID 10761650 DOI: 10.3171/jns.2000.92.4.0615 |
0.355 |
|
| 2000 |
Mouatt-Prigent A, Karlsson JO, Yelnik J, Agid Y, Hirsch EC. Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease. The Journal of Comparative Neurology. 419: 175-92. PMID 10722997 DOI: 10.1002/(SICI)1096-9861(20000403)419:2<175::AID-CNE3>3.0.CO;2-2 |
0.419 |
|
| 2000 |
Périer C, Vila M, Féger J, Agid Y, Hirsch EC. Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats. Experimental Neurology. 162: 215-24. PMID 10716902 DOI: 10.1006/exnr.1999.7331 |
0.345 |
|
| 2000 |
Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 97: 2875-80. PMID 10688892 DOI: 10.1073/pnas.040556597 |
0.367 |
|
| 2000 |
Vila M, Périer C, Féger J, Yelnik J, Faucheux B, Ruberg M, Raisman-Vozari R, Agid Y, Hirsch EC. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. The European Journal of Neuroscience. 12: 337-44. PMID 10651888 DOI: 10.1046/J.1460-9568.2000.00901.X |
0.304 |
|
| 2000 |
Kubis N, Faucheux BA, Ransmayr G, Damier P, Duyckaerts C, Henin D, Forette B, Le Charpentier Y, Hauw JJ, Agid Y, Hirsch EC. Preservation of midbrain catecholaminergic neurons in very old human subjects. Brain : a Journal of Neurology. 123: 366-73. PMID 10648443 DOI: 10.1093/Brain/123.2.366 |
0.383 |
|
| 2000 |
Lehéricy S, Gerardin E, Poline J, Sirigu A, Marsault C, Le Bihan D, Agid Y, Vidailhet M. Cortico-subcortical reorganization of the motor system in patients with symptomatic unilateral dystonia Neuroimage. 11: S166. DOI: 10.1016/S1053-8119(00)91099-1 |
0.3 |
|
| 1999 |
Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 911-3. PMID 10584663 DOI: 10.1002/1531-8257(199911)14:6<911::Aid-Mds1001>3.0.Co;2-H |
0.401 |
|
| 1999 |
Faucheux BA, Bonnet AM, Agid Y, Hirsch EC. Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet. 353: 981-2. PMID 10459912 DOI: 10.1016/S0140-6736(99)00641-8 |
0.353 |
|
| 1999 |
Vidailhet M, Dupel C, Lehéricy S, Remy P, Dormont D, Serdaru M, Jedynak P, Veber H, Samson Y, Marsault C, Agid Y. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. Archives of Neurology. 56: 982-9. PMID 10448804 DOI: 10.1001/Archneur.56.8.982 |
0.347 |
|
| 1999 |
Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Annals of Neurology. 46: 217-23. PMID 10443887 DOI: 10.1002/1531-8249(199908)46:2<217::Aid-Ana11>3.0.Co;2-Z |
0.356 |
|
| 1999 |
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain : a Journal of Neurology. 122: 1437-48. PMID 10430830 DOI: 10.1093/brain/122.8.1437 |
0.381 |
|
| 1999 |
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain : a Journal of Neurology. 122: 1421-36. PMID 10430829 DOI: 10.1093/brain/122.8.1421 |
0.381 |
|
| 1999 |
Bédard MA, Pillon B, Dubois B, Duchesne N, Masson H, Agid Y. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome. Brain and Cognition. 40: 289-313. PMID 10413563 DOI: 10.1006/brcg.1999.1083 |
0.362 |
|
| 1999 |
Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience. 88: 1015-32. PMID 10336117 DOI: 10.1016/S0306-4522(98)00219-X |
0.347 |
|
| 1999 |
Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, Dormont D, Cornu P, Pidoux B, Samson Y, Agid Y. Transient acute depression induced by high-frequency deep-brain stimulation. The New England Journal of Medicine. 340: 1476-80. PMID 10320386 DOI: 10.1056/NEJM199905133401905 |
0.332 |
|
| 1999 |
Michel PP, Marien M, Ruberg M, Colpaert F, Agid Y. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. Journal of Neurochemistry. 72: 2074-82. PMID 10217287 DOI: 10.1046/J.1471-4159.1999.0722074.X |
0.326 |
|
| 1999 |
Parain K, Murer MG, Yan Q, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. Neuroreport. 10: 557-61. PMID 10208589 DOI: 10.1097/00001756-199902250-00021 |
0.352 |
|
| 1999 |
Hirsch E, Hu LJ, Prigent A, Constantin B, Agid Y, Drabkin H, Roche J. Distribution of semaphorin IV in adult human brain. Brain Research. 823: 67-79. PMID 10095013 DOI: 10.1016/S0006-8993(99)01103-8 |
0.303 |
|
| 1999 |
Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 383-5. PMID 10091646 DOI: 10.1002/1531-8257(199903)14:2<383::Aid-Mds1037>3.0.Co;2-F |
0.383 |
|
| 1999 |
Sabbagh N, Brice A, Marez D, Dürr A, Legrand M, Lo Guidice JM, Destée A, Agid Y, Broly F. CYP2D6 polymorphism and Parkinson's disease susceptibility. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 230-6. PMID 10091614 DOI: 10.1002/1531-8257(199903)14:2<230::Aid-Mds1005>3.0.Co;2-6 |
0.344 |
|
| 1999 |
Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, ... ... Agid Y, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Human Molecular Genetics. 8: 567-74. PMID 10072423 DOI: 10.1093/Hmg/8.4.567 |
0.359 |
|
| 1999 |
Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Bmj (Clinical Research Ed.). 318: 633-8. PMID 10066203 DOI: 10.1136/Bmj.318.7184.633 |
0.305 |
|
| 1998 |
Villares J, Faucheux B, Herrero MT, Obeso JA, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC. [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys. Experimental Neurology. 154: 146-56. PMID 9875276 DOI: 10.1006/Exnr.1998.6933 |
0.427 |
|
| 1998 |
Bejjani BP, Damier P, Arnulf I, Papadopoulos S, Bonnet AM, Vidailhet M, Agid Y, Pidoux B, Cornu P, Dormont D, Marsault C. Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 969-70. PMID 9827624 DOI: 10.1002/Mds.870130618 |
0.354 |
|
| 1998 |
Vidailhet M, Jedynak CP, Pollak P, Agid Y. Pathology of symptomatic tremors. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 49-54. PMID 9827595 DOI: 10.1002/Mds.870131309 |
0.318 |
|
| 1998 |
Zalla T, Sirigu A, Pillon B, Dubois B, Grafman J, Agid Y. Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 34: 621-7. PMID 9800095 DOI: 10.1016/S0010-9452(08)70519-7 |
0.351 |
|
| 1998 |
Dumanchin C, Camuzat A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier-Veber P, Martin C, Penet C, Charbonnier F, Agid Y, Frebourg T, Brice A. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Human Molecular Genetics. 7: 1825-9. PMID 9736786 DOI: 10.1093/Hmg/7.11.1825 |
0.331 |
|
| 1998 |
Dumanchin C, Brice A, Campion D, Hannequin D, Martin C, Moreau V, Agid Y, Martinez M, Clerget-Darpoux F, Frebourg T. De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group. Journal of Medical Genetics. 35: 672-3. PMID 9719376 DOI: 10.1136/Jmg.35.8.672 |
0.321 |
|
| 1998 |
Vaughan J, Durr A, Tassin J, Bereznai B, Gasser T, Bonifati V, De Michele G, Fabrizio E, Volpe G, Bandmann O, Johnson WG, Golbe LI, Breteler M, Meco G, Agid Y, et al. The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease. Annals of Neurology. 44: 270-3. PMID 9708553 DOI: 10.1002/Ana.410440221 |
0.36 |
|
| 1998 |
Benisty S, Boissiere F, Faucheux B, Agid Y, Hirsch EC. trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study. Neuroscience. 86: 813-26. PMID 9692719 DOI: 10.1016/S0306-4522(98)00126-2 |
0.351 |
|
| 1998 |
Boissière F, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC. Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease. Journal of Neurochemistry. 71: 767-74. PMID 9681468 DOI: 10.1046/J.1471-4159.1998.71020767.X |
0.351 |
|
| 1998 |
Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology. 55: 969-78. PMID 9678315 DOI: 10.1001/Archneur.55.7.969 |
0.351 |
|
| 1998 |
Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw JJ, Trottier Y, Brice A, Agid Y, Hirsch EC. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset. Neuroreport. 9: 1823-6. PMID 9665608 DOI: 10.1097/00001756-199806010-00028 |
0.368 |
|
| 1998 |
Tassin J, Dürr A, de Broucker T, Abbas N, Bonifati V, De Michele G, Bonnet AM, Broussolle E, Pollak P, Vidailhet M, De Mari M, Marconi R, Medjbeur S, Filla A, Meco G, ... Agid Y, et al. Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consortium on Genetic Susceptibility in Parkinson's Disease. American Journal of Human Genetics. 63: 88-94. PMID 9634531 DOI: 10.1086/301934 |
0.317 |
|
| 1998 |
Murer MG, Dziewczapolski G, Menalled LB, GarcÃa MC, Agid Y, Gershanik O, Raisman-Vozari R. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Annals of Neurology. 43: 561-75. PMID 9585350 DOI: 10.1002/Ana.410430504 |
0.34 |
|
| 1998 |
Agid Y. Levodopa: is toxicity a myth? Neurology. 50: 858-63. PMID 9566363 DOI: 10.1212/Wnl.50.4.858 |
0.326 |
|
| 1998 |
Holmberg M, Duyckaerts C, Dürr A, Cancel G, Gourfinkel-An I, Damier P, Faucheux B, Trottier Y, Hirsch EC, Agid Y, Brice A. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Human Molecular Genetics. 7: 913-8. PMID 9536097 DOI: 10.1093/Hmg/7.5.913 |
0.368 |
|
| 1998 |
Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, Agid Y, Bonifati V, DeMichele G, Volpe G, Lincoln S, Breteler M, Meco G, Brice A, Marsden CD, Hardy J, et al. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Human Molecular Genetics. 7: 751-3. PMID 9499430 DOI: 10.1093/Hmg/7.4.751 |
0.334 |
|
| 1998 |
Cancel G, Gourfinkel-An I, Stevanin G, Didierjean O, Abbas N, Hirsch E, Agid Y, Brice A. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Human Mutation. 11: 23-7. PMID 9450899 DOI: 10.1002/(Sici)1098-1004(1998)11:1<23::Aid-Humu4>3.0.Co;2-M |
0.355 |
|
| 1998 |
David G, Dürr A, Stevanin G, Cancel G, Abbas N, Benomar A, Belal S, Lebre AS, Abada-Bendib M, Grid D, Holmberg M, Yahyaoui M, Hentati F, Chkili T, Agid Y, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Human Molecular Genetics. 7: 165-70. PMID 9425222 DOI: 10.1093/Hmg/7.2.165 |
0.338 |
|
| 1998 |
Bejjani B, Damier P, Arnulf I, Bonnet AM, Vidailhet M, Dormont D, Pidoux B, Cornu P, Marsault C, Agid Y. Antiparkinsonian and anti-levodopa-induced dyskinesia effects obtained by stimulating the same site within the GPi in PD Neurology. 51: 1776-1777. DOI: 10.1212/Wnl.51.6.1776-B |
0.332 |
|
| 1998 |
Agid Y, Dubois B, Anand R, Gharabawi G. Efficacy And Tolerability Of Rivastigmine In Patients With Dementia Of The Alzheimer Type Current Therapeutic Research-Clinical and Experimental. 59: 837-845. DOI: 10.1016/S0011-393X(98)85048-0 |
0.304 |
|
| 1997 |
Bejjani B, Damier P, Arnulf I, Bonnet AM, Vidailhet M, Dormont D, Pidoux B, Cornu P, Marsault C, Agid Y. Pallidal stimulation for Parkinson's disease. Two targets? Neurology. 49: 1564-9. PMID 9409347 DOI: 10.1212/Wnl.49.6.1564 |
0.353 |
|
| 1997 |
Gourfinkel-An I, Cancel G, Trottier Y, Devys D, Tora L, Lutz Y, Imbert G, Saudou F, Stevanin G, Agid Y, Brice A, Mandel JL, Hirsch EC. Differential distribution of the normal and mutated forms of huntingtin in the human brain. Annals of Neurology. 42: 712-9. PMID 9392570 DOI: 10.1002/Ana.410420507 |
0.341 |
|
| 1997 |
Boissière F, Hunot S, Faucheux B, Duyckaerts C, Hauw JJ, Agid Y, Hirsch EC. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport. 8: 2849-52. PMID 9376517 DOI: 10.1097/00001756-199709080-00009 |
0.316 |
|
| 1997 |
Stevanin G, Dürr A, David G, Didierjean O, Cancel G, Rivaud S, Tourbah A, Warter JM, Agid Y, Brice A. Clinical and molecular features of spinocerebellar ataxia type 6. Neurology. 49: 1243-6. PMID 9371901 DOI: 10.1212/Wnl.49.5.1243 |
0.304 |
|
| 1997 |
France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. Journal of Neurochemistry. 69: 1612-21. PMID 9326290 DOI: 10.1046/J.1471-4159.1997.69041612.X |
0.314 |
|
| 1997 |
Michel PP, Ruberg M, Agid Y. Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. Journal of Neurochemistry. 69: 1499-507. PMID 9326279 DOI: 10.1046/J.1471-4159.1997.69041499.X |
0.334 |
|
| 1997 |
Agid Y, Destée A, Durif F, Montastruc JL, Pollak P. Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group. Lancet. 350: 712-3. PMID 9291909 DOI: 10.1016/S0140-6736(05)63511-8 |
0.362 |
|
| 1997 |
David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, ... ... Agid Y, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genetics. 17: 65-70. PMID 9288099 DOI: 10.1038/Ng0997-65 |
0.303 |
|
| 1997 |
Bonnet AM, Pichon J, Vidailhet M, Gouider-Khouja N, Robain G, Perrigot M, Agid Y. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 509-13. PMID 9251068 DOI: 10.1002/Mds.870120406 |
0.343 |
|
| 1997 |
Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 49: 62-9. PMID 9222171 DOI: 10.1212/Wnl.49.1.62 |
0.33 |
|
| 1997 |
Didierjean O, Martinez M, Campion D, Hannequin D, Dubois B, Martin C, Puel M, Thomas Anterion C, Pasquier F, Moreau O, Babron MC, Penet C, Agid Y, Clerget-Darpoux F, Frebourg T, et al. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 103-5. PMID 9221977 DOI: 10.1136/Jnnp.63.1.103 |
0.328 |
|
| 1997 |
Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 94: 7531-6. PMID 9207126 DOI: 10.1073/Pnas.94.14.7531 |
0.348 |
|
| 1997 |
Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F, Hibner U, Agid Y. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. Journal of Neurochemistry. 69: 223-31. PMID 9202314 DOI: 10.1046/J.1471-4159.1997.69010223.X |
0.329 |
|
| 1997 |
Boissiere F, Faucheux B, Ruberg M, Agid Y, Hirsch EC. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Experimental Neurology. 145: 245-52. PMID 9184126 DOI: 10.1006/exnr.1997.6443 |
0.394 |
|
| 1997 |
Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain : a Journal of Neurology. 120: 813-23. PMID 9183252 DOI: 10.1093/Brain/120.5.813 |
0.341 |
|
| 1997 |
Cancel G, Dürr A, Didierjean O, Imbert G, Bürk K, Lezin A, Belal S, Benomar A, Abada-Bendib M, Vial C, Guimarães J, Chneiweiss H, Stevanin G, Yvert G, Abbas N, ... ... Agid Y, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Human Molecular Genetics. 6: 709-15. PMID 9158145 DOI: 10.1093/Hmg/6.5.709 |
0.331 |
|
| 1997 |
Boissière F, Faucheux B, Agid Y, Hirsch EC. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease. Neuroscience Letters. 225: 169-72. PMID 9147397 DOI: 10.1016/S0304-3940(97)00210-3 |
0.379 |
|
| 1997 |
Boissière F, Faucheux B, Agid Y, Hirsch EC. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study Neuroscience Letters. 221: 141-144. PMID 9121684 DOI: 10.1016/S0304-3940(96)13306-1 |
0.363 |
|
| 1997 |
Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y. Neuronal vulnerability in Parkinson's disease. Journal of Neural Transmission-Supplement. 50: 79-88. PMID 9120427 DOI: 10.1007/978-3-7091-6842-4_9 |
0.356 |
|
| 1997 |
Ruberg M, Brugg B, Prigent A, Hirsch E, Brice A, Agid Y. Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? Journal of Neurochemistry. 68: 2098-110. PMID 9109538 DOI: 10.1046/J.1471-4159.1997.68052098.X |
0.353 |
|
| 1997 |
Faucheux BA, Hauw JJ, Agid Y, Hirsch EC. The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease. Brain Research. 749: 170-4. PMID 9070646 DOI: 10.1016/S0006-8993(96)01412-6 |
0.38 |
|
| 1997 |
Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y. Low-dose clozapine improves dyskinesias in Parkinson's disease. Neurology. 48: 658-62. PMID 9065543 DOI: 10.1212/WNL.48.3.658 |
0.377 |
|
| 1997 |
Levy R, Hazrati LN, Herrero MT, Vila M, Hassani OK, Mouroux M, Ruberg M, Asensi H, Agid Y, Féger J, Obeso JA, Parent A, Hirsch EC. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience. 76: 335-43. PMID 9015319 DOI: 10.1016/S0306-4522(96)00409-5 |
0.403 |
|
| 1997 |
Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RKB, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study Neurology. 48: 119-125. PMID 9008506 DOI: 10.1212/Wnl.48.1.119 |
0.321 |
|
| 1997 |
Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 8: 1-8. PMID 8997546 DOI: 10.1159/000106594 |
0.32 |
|
| 1997 |
Boissière F, Lehéricy S, Strada O, Agid Y, Hirsch EC. Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease. Molecular and Chemical Neuropathology. 28: 219-23. PMID 8871962 DOI: 10.1007/BF02815225 |
0.317 |
|
| 1997 |
Vila M, Levy R, Herrero M, Ruberg M, Faucheux B, Obeso JA, Agid Y, Hirsch EC. Consequences of Nigrostriatal Denervation on the Functioning of the Basal Ganglia in Human and Nonhuman Primates: AnIn SituHybridization Study of Cytochrome Oxidase Subunit I mRNA The Journal of Neuroscience. 17: 765-773. DOI: 10.1523/JNEUROSCI.17-02-00765.1997 |
0.353 |
|
| 1996 |
Adelbrecht C, Agid Y, Raisman-Vozari R. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area. Molecular Brain Research. 43: 291-300. PMID 9037545 DOI: 10.1016/S0169-328X(96)00214-8 |
0.316 |
|
| 1996 |
Hunot S, Bernard V, Faucheux B, Boissière F, Leguern E, Brana C, Gautris PP, Guérin J, Bloch B, Agid Y, Hirsch EC. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease Journal of Neural Transmission. 103: 1043-1052. PMID 9013392 DOI: 10.1007/Bf01291789 |
0.408 |
|
| 1996 |
Pezzoli G, Strada O, Silani V, Zecchinelli A, Perbellini L, Javoy‐Agid F, Ghidoni P, Motti EDF, Masini T, Scarlato G, Agid Y, Hirsch EC. Clinical and pathological features in hydrocarbon-induced parkinsonism. Annals of Neurology. 40: 922-925. PMID 9007099 DOI: 10.1002/Ana.410400616 |
0.379 |
|
| 1996 |
Chritin M, Blanchard V, Raisman-Vozari R, Feuerstein C, Agid Y, Javoy-Agid F, Savasta M. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration. European Journal of Neuroscience. 8: 2511-2520. PMID 8996800 DOI: 10.1111/J.1460-9568.1996.Tb01545.X |
0.338 |
|
| 1996 |
Stevanin G, Trottier Y, Cancel G, Dürr A, David G, Didierjean O, Bürk K, Imbert G, Saudou F, Abada-Bendib M, Gourfinkel-An I, Benomar A, Abbas N, Klockgether T, Grid D, ... Agid Y, et al. Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Human Molecular Genetics. 5: 1887-92. PMID 8968739 DOI: 10.1093/Hmg/5.12.1887 |
0.332 |
|
| 1996 |
Guridi J, Herrero MT, Luquin MR, Guillén J, Ruberg M, Laguna J, Vila M, Javoy-Agid F, Agid Y, Hirsch E, Obeso JA. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain : a Journal of Neurology. 119: 1717-27. PMID 8931592 DOI: 10.1093/Brain/119.5.1717 |
0.325 |
|
| 1996 |
Herrero MT, Augood SJ, Asensi H, Hirsch EC, Agid Y, Obeso JA, Emson PC. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Brain Research. Molecular Brain Research. 42: 149-55. PMID 8915594 DOI: 10.1016/S0169-328X(96)00157-X |
0.326 |
|
| 1996 |
Boissière F, Pradier L, Delaère P, Faucheux B, Revah F, Brice A, Agid Y, Hirsch EC. Regional and cellular presenilin 2 (STM2) gene expression in the human brain. Neuroreport. 7: 2021-2025. PMID 8905717 DOI: 10.1097/00001756-199608120-00034 |
0.346 |
|
| 1996 |
Hannequin D, Campion D, Brice A, Frebourg T, Martinez M, Clerget-Darpoux F, Agid Y. Genetics of Alzheimer's disease Revue De Medecine Interne. 17: 545-550. PMID 8881379 DOI: 10.1016/0248-8663(96)83090-6 |
0.303 |
|
| 1996 |
Campion D, Brice A, Hannequin D, Charbonnier F, Dubois B, Martin C, Michon A, Penet C, Bellis M, Calenda A, Martinez M, Agid Y, Clerget-Darpoux F, Frebourg T, Thomas-Anterion C, et al. No founder effect in three novel Alzheimer's disease families with APP 717 Val → Ile mutation Journal of Medical Genetics. 33: 661-664. PMID 8863158 DOI: 10.1136/Jmg.33.8.661 |
0.318 |
|
| 1996 |
Pillon B, Ertle S, Deweer B, Sarazin M, Agid Y, Dubois B. Memory for spatial location is affected in Parkinson's disease. Neuropsychologia. 34: 77-85. PMID 8852695 DOI: 10.1016/0028-3932(95)00086-0 |
0.305 |
|
| 1996 |
Pillon B, Dubois B, Agid Y. Cognitive deficits in non-Alzheimer's degenerative diseases. Journal of Neural Transmission-Supplement. 47: 61-71. PMID 8841957 DOI: 10.1007/978-3-7091-6892-9_4 |
0.36 |
|
| 1996 |
Anglade P, Mouatt-Prigent A, Agid Y, Hirsch EC. Synaptic Plasticity in the Caudate Nucleus of Patients with Parkinson's Disease Neurodegeneration. 5: 121-128. PMID 8819132 DOI: 10.1006/Neur.1996.0018 |
0.361 |
|
| 1996 |
Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel J, Brice A, Koenig M. Clinical And Genetic Abnormalities In Patients With Friedreich'S Ataxia The New England Journal of Medicine. 335: 1169-1175. PMID 8815938 DOI: 10.1056/Nejm199610173351601 |
0.345 |
|
| 1996 |
Verny M, Duyckaerts C, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain : a Journal of Neurology. 119: 1123-36. PMID 8813277 DOI: 10.1093/Brain/119.4.1123 |
0.301 |
|
| 1996 |
Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience. 73: 979-87. PMID 8809817 DOI: 10.1016/0306-4522(96)00100-5 |
0.383 |
|
| 1996 |
Billette de Villemeur T, Deslys JP, Pradel A, Soubrié C, Alpérovitch A, Tardieu M, Chaussain JL, Hauw JJ, Dormont D, Ruberg M, Agid Y. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 47: 690-5. PMID 8797466 DOI: 10.1212/Wnl.47.3.690 |
0.332 |
|
| 1996 |
Partiot A, Vérin M, Pillon B, Teixeira-Ferreira C, Agid Y, Dubois B. Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation. Neuropsychologia. 34: 709-721. PMID 8783222 DOI: 10.1016/0028-3932(95)00143-3 |
0.313 |
|
| 1996 |
Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, Hof PR. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathologica. 91: 566-72. PMID 8781654 DOI: 10.1007/s004010050468 |
0.407 |
|
| 1996 |
Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB. Accuracy of Clinical Criteria for the Diagnosis of Progressive Supranuclear Palsy (Steele-Richardson-Olszewski Syndrome) Neurology. 46: 922-930. PMID 8780065 DOI: 10.1212/Wnl.46.4.922 |
0.339 |
|
| 1996 |
Bernard V, Gardiol A, Faucheux B, Bloch B, Agid Y, Hirsch EC. Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in parkinson's disease and rat with 6-OHDA lesion The Journal of Comparative Neurology. 368: 553-568. PMID 8744443 DOI: 10.1002/(Sici)1096-9861(19960513)368:4<553::Aid-Cne7>3.0.Co;2-3 |
0.37 |
|
| 1996 |
Hunot S, Boissière F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease Neuroscience. 72: 355-363. PMID 8737406 DOI: 10.1016/0306-4522(95)00578-1 |
0.347 |
|
| 1996 |
Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology. 47: 219-24. PMID 8710082 DOI: 10.1212/WNL.47.1.219 |
0.314 |
|
| 1996 |
Vila M, Levy R, Herrero MT, Faucheux B, Obeso JA, Agid Y, Hirsch EC. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neuroscience. 71: 903-12. PMID 8684621 DOI: 10.1016/0306-4522(95)00549-8 |
0.342 |
|
| 1996 |
Carpentier AF, Bonnet AM, Vidailhet M, Agid Y. Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease. Neurology. 46: 1548-51. PMID 8649546 DOI: 10.1212/WNL.46.6.1548 |
0.385 |
|
| 1996 |
Damier P, Kastner A, Agid Y, Hirsch EC. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease? Neurology. 46: 1262-1262. PMID 8628464 DOI: 10.1212/Wnl.46.5.1262 |
0.346 |
|
| 1996 |
Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, Chneiweiss H, Benomar A, Lyon-Caen O, Julien J, Serdaru M, Penet C, Agid Y, Brice A. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Annals of Neurology. 39: 490-9. PMID 8619527 DOI: 10.1002/Ana.410390411 |
0.352 |
|
| 1996 |
Vila M, Herrero MT, Levy R, Faucheux B, Ruberg M, Guillen J, Luquin MR, Guridi J, Javoy-Agid F, Agid Y, Obeso JA, Hirsch EC. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology. 46: 802-9. PMID 8618687 DOI: 10.1212/WNL.46.3.802 |
0.393 |
|
| 1996 |
Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders Neurology. 46: 329-334. PMID 8614489 DOI: 10.1212/Wnl.46.2.329 |
0.373 |
|
| 1996 |
Campion D, Brice A, Agid Y, Martinez M, Frebourg T, Clerget-Darpoux F, Dubois B. 784 Genetic studies of Alzheimer's disease in 434 French families Neurobiology of Aging. 17: S195. DOI: 10.1016/S0197-4580(96)80786-X |
0.306 |
|
| 1996 |
Litvan I, Agid Y, Brandel JP, Goetz C, Jankovic J, Lai EC, Wenning G. 641 Accuracy of the clinical diagnosis of pick's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80643-9 |
0.303 |
|
| 1995 |
Blin J, Horwitz B, Baron JC, Agid Y. Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 1: 221-8. PMID 24283522 DOI: 10.1111/j.1468-1331.1995.tb00075.x |
0.311 |
|
| 1995 |
Pérez-Tur J, Campion D, Martinez M, Brice A, Tardieu S, Hannequin D, Agid Y, Delacourte A, Clerget-Darpoux F, Chartier-Harlin MC. Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. American Journal of Medical Genetics. 60: 550-3. PMID 8825894 DOI: 10.1002/Ajmg.1320600613 |
0.309 |
|
| 1995 |
Faucheux BA, Herrero MT, Villares J, Levy R, Javoy-Agid F, Obeso JA, Hauw JJ, Agid Y, Hirsch EC. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys. Brain Research. 691: 115-24. PMID 8590043 DOI: 10.1016/0006-8993(95)00629-5 |
0.395 |
|
| 1995 |
Levy R, Vila M, Herrero M, Faucheux B, Agid Y, Hirsch EC. Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease Neuroscience Letters. 199: 220-224. PMID 8577402 DOI: 10.1016/0304-3940(95)12011-R |
0.369 |
|
| 1995 |
Stevanin G, Cassa E, Cancel G, Abbas N, Dürr A, Jardim E, Agid Y, Sousa PS, Brice A. Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease Journal of Medical Genetics. 32: 827-830. PMID 8558567 DOI: 10.1136/Jmg.32.10.827 |
0.309 |
|
| 1995 |
Bonnet AM, Serre I, Marconi R, Agid Y, Dubois B. A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine Movement Disorders. 10: 668-671. PMID 8552122 DOI: 10.1002/Mds.870100522 |
0.332 |
|
| 1995 |
Thibaut F, Faucheux BA, Marquez J, Villares J, Menard JF, Agid Y, Hirsch EC. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine Brain Research. 692: 233-243. PMID 8548309 DOI: 10.1016/0006-8993(95)00674-F |
0.335 |
|
| 1995 |
Remy P, Hosseini H, Degos J, Samson Y, Agid Y, Warter J, Vidailhet M. Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography. Annals of Neurology. 38: 954-956. PMID 8526470 DOI: 10.1002/Ana.410380618 |
0.366 |
|
| 1995 |
Brandel JP, Marconi R, Serdaru M, Vidailhet M, Agid Y. Down's syndrome and Parkinson's disease. Neurology. 44: 2419-20. PMID 7991152 DOI: 10.1212/Wnl.44.12.2419-C |
0.349 |
|
| 1995 |
Pillon B, Gouider-Khouja N, Deweer B, Vidailhet M, Malapani C, Dubois B, Agid Y. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 174-9. PMID 7876847 DOI: 10.1136/Jnnp.58.2.174 |
0.38 |
|
| 1995 |
Ruberg M, Scherman D, Javoy-Agid F, Agid Y. Dopamine denervation, age of onset, and Parkinson's disease. Neurology. 45: 392-392. PMID 7854549 DOI: 10.1212/Wnl.45.2.392 |
0.366 |
|
| 1995 |
Dubourg O, Dürr A, Cancel G, Stevanin G, Penet C, Agid Y, Brice A, Chneiweiss H. Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Annals of Neurology. 37: 176-180. PMID 7847859 DOI: 10.1002/Ana.410370207 |
0.304 |
|
| 1995 |
Campion D, Brice A, Hannequin D, Tardieu S, Dubois B, Calenda A, Brun E, Penet C, Tayot J, Martinez M, Bellis M, Mallet J, Agid Y, Clerget-Darpoux F. A large pedigree with early-onset alzheimer's disease: Clinical, neuropathologic, and genetic characterization Neurology. 45: 80-85. PMID 7824141 DOI: 10.1212/Wnl.45.1.80 |
0.33 |
|
| 1995 |
Levy R, Ruberg M, Herrero MT, Villares J, Javoy-Agid F, Agid Y, Hirsch EC. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy An in situ hybridization study of GAD67 messenger RNA Neurology. 45: 127-134. PMID 7824102 DOI: 10.1212/Wnl.45.1.127 |
0.358 |
|
| 1995 |
Dürr A, Dodé C, Hahn V, Pêcheux C, Pillon B, Feingold J, Kaplan JC, Agid Y, Brice A. Diagnosis of "sporadic" Huntington's disease. Journal of the Neurological Sciences. 129: 51-5. PMID 7751845 DOI: 10.1016/0022-510X(94)00250-R |
0.376 |
|
| 1995 |
Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 288-94. PMID 7651445 DOI: 10.1002/Mds.870100310 |
0.41 |
|
| 1995 |
Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genetics. 10: 104-10. PMID 7647777 DOI: 10.1038/Ng0595-104 |
0.326 |
|
| 1995 |
Pillon B, Blin J, Vidailhet M, Deweer B, Sirigu A, Dubois B, Agid Y. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology. 45: 1477-83. PMID 7644044 DOI: 10.1212/Wnl.45.8.1477 |
0.377 |
|
| 1995 |
Anglade P, Tsuji S, Agid Y, Hirsch EC. Neuronal Plasticity And Parkinson Disease Molecular and Chemical Neuropathology. 24: 251-255. PMID 7632329 DOI: 10.1007/Bf02962152 |
0.354 |
|
| 1995 |
Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 9603-7. PMID 7568181 DOI: 10.1073/Pnas.92.21.9603 |
0.362 |
|
| 1995 |
Dürr A, Stevanin G, Cancel G, Abbas N, Chneiweiss H, Agid Y, Feingold J, Brice A. Gender equality in Machado-Joseph disease. Nature Genetics. 11: 118-9. PMID 7550335 DOI: 10.1038/Ng1095-118A |
0.302 |
|
| 1995 |
Brice A, Tardieu S, Campion D, Le Guern E, Martinez M, Carpentier A, Penet C, Dubois B, Bellis M, Mallet J, Hannequin D, Clerget-Darpoux F, Agid Y, Michon A, Pillon B, et al. Allelic association at the D14S43 locus in early onset Alzheimer's disease American Journal of Medical Genetics - Neuropsychiatric Genetics. 60: 91-93. PMID 7485257 DOI: 10.1002/Ajmg.1320600202 |
0.36 |
|
| 1995 |
Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y. Levodopa-induced dyskinesias are improved by fluoxetine. Neurology. 45: 1855-8. PMID 7477981 DOI: 10.1212/WNL.45.10.1855 |
0.363 |
|
| 1994 |
Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction. Neurology. 44: 319-26. PMID 8309583 DOI: 10.1212/Wnl.44.2.319 |
0.35 |
|
| 1994 |
Malessa S, Gaymard B, Rivaud S, Cervera P, Hirsch E, Verny M, Duyckaerts C, Agid Y, Pierrot-Deseilligny C. Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology. 44: 716-21. PMID 8164832 DOI: 10.1212/Wnl.44.4.716 |
0.336 |
|
| 1994 |
Vermersch AI, Rivaud S, Vidailhet M, Bonnet AM, Gaymard B, Agid Y, Pierrot-Deseilligny C. Sequences of memory-guided saccades in Parkinson's disease. Annals of Neurology. 35: 487-90. PMID 8154878 DOI: 10.1002/Ana.410350419 |
0.336 |
|
| 1994 |
Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet AM, Gaymard B, Agid Y, Pierrot-Deseilligny C. Eye movements in parkinsonian syndromes. Annals of Neurology. 35: 420-6. PMID 8154868 DOI: 10.1002/Ana.410350408 |
0.316 |
|
| 1994 |
Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 2-12. PMID 8139601 DOI: 10.1002/Mds.870090103 |
0.409 |
|
| 1994 |
Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease Neuroscience Letters. 172: 151-154. PMID 8084523 DOI: 10.1016/0304-3940(94)90684-X |
0.376 |
|
| 1994 |
Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Annals of Neurology. 36: 348-355. PMID 8080242 DOI: 10.1002/Ana.410360305 |
0.424 |
|
| 1994 |
Dürr A, Brice A, Serdaru M, Rancurel G, Derouesné C, Lyon-Caen O, Agid Y, Fontaine B. The phenotype of “pure” autosomal dominant spastic paraplegia Neurology. 44: 1274-1274. PMID 8035929 DOI: 10.1212/Wnl.44.7.1274 |
0.313 |
|
| 1994 |
Pillon B, Deweer B, Michon A, Malapani C, Agid Y, Dubois B. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology. 44: 1264-70. PMID 8035927 DOI: 10.1212/Wnl.44.7.1264 |
0.312 |
|
| 1994 |
Holemans S, Javoy-Agid F, Agid Y, Paermentier FD, Laterre E, Maloteaux J. Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease Brain Research. 642: 327-333. PMID 8032896 DOI: 10.1016/0006-8993(94)90938-5 |
0.378 |
|
| 1994 |
Mazzetti P, Le Guern E, Bonnet AM, Vidailhet M, Brice A, Agid Y. Familial Parkinson's disease and polymorphism at the CYP2D6 locus. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 871-2. PMID 8021689 DOI: 10.1136/Jnnp.57.7.871 |
0.344 |
|
| 1994 |
Michon A, Deweer B, Pillon B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 805-809. PMID 8021665 DOI: 10.1136/Jnnp.57.7.805 |
0.322 |
|
| 1994 |
Zhang P, Anglade P, Hirsch EC, Javoy-Agid F, Agid Y. Distribution of manganese-dependent superoxide dismutase in the human brain. Neuroscience. 61: 317-330. PMID 7969912 DOI: 10.1016/0306-4522(94)90234-8 |
0.317 |
|
| 1994 |
Vidailhet M, Bonnet AM, Marconi R, Gouider-Khouja N, Agid Y. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot? Neurology. 44: 1613-6. PMID 7936284 DOI: 10.1212/Wnl.44.9.1613 |
0.386 |
|
| 1994 |
Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA, Agid Y. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy. Annals of Neurology. 36: 206-14. PMID 7914399 DOI: 10.1002/ana.410360213 |
0.357 |
|
| 1994 |
Michel PP, Vyas S, Anglade P, Ruberg M, Agid Y. Morphological and Molecular Characterization of the Response of Differentiated PC12 Cells to Calcium Stress European Journal of Neuroscience. 6: 577-586. PMID 7912984 DOI: 10.1111/J.1460-9568.1994.Tb00302.X |
0.321 |
|
| 1994 |
Blanchard V, Raisman-Vozari R, Vyas S, Michel PP, Uhl G, Agid Y. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon Molecular Brain Research. 22: 29-38. PMID 7912404 DOI: 10.1016/0169-328X(94)90029-9 |
0.324 |
|
| 1994 |
Villares J, Strada O, Faucheux B, Agid Y, Hirsch EC. Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease. Neuroscience Letters. 182: 59-62. PMID 7891888 DOI: 10.1016/0304-3940(94)90205-4 |
0.382 |
|
| 1994 |
Dournaud P, Cervera-Pierot P, Hirsch E, Javoy-Agid F, Kordon CL, Agid Y, Epelbaum J. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience. 61: 755-764. PMID 7838375 DOI: 10.1016/0306-4522(94)90399-9 |
0.341 |
|
| 1994 |
Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y. Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography. Brain Research. 659: 1-9. PMID 7820649 DOI: 10.1016/0006-8993(94)90856-7 |
0.397 |
|
| 1994 |
Mouatt-Prigent A, Agid Y, Hirsch EC. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? Brain Research. 668: 62-70. PMID 7704619 DOI: 10.1016/0006-8993(94)90511-8 |
0.37 |
|
| 1993 |
Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Lévy D, Pillon B, Fournier D, Vidailhet M, Agid Y. Loss of brain 5-HT2receptors in Alzheimer's diseaseIn vivo assessment with positron emission tomography and (18)setoperone Brain. 116: 497-510. PMID 8513389 DOI: 10.1093/Brain/116.3.497 |
0.325 |
|
| 1993 |
Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Annals of Neurology. 33: 445-50. PMID 8498822 DOI: 10.1002/Ana.410330506 |
0.372 |
|
| 1993 |
Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y. Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. Journal of Neurochemistry. 60: 2338-41. PMID 8492137 DOI: 10.1111/J.1471-4159.1993.Tb03527.X |
0.362 |
|
| 1993 |
Lehéricy S, Hirsch EC, Cervera-Piérot P, Hersh LB, Bakchine S, Piette F, Duyckaerts C, Hauw JJ, Javoy-Agid F, Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. The Journal of Comparative Neurology. 330: 15-31. PMID 8468401 DOI: 10.1002/Cne.903300103 |
0.326 |
|
| 1993 |
Pillon B, Deweer B, Agid Y, Dubois B. Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases Jama Neurology. 50: 374-379. PMID 8460958 DOI: 10.1001/Archneur.1993.00540040036010 |
0.363 |
|
| 1993 |
Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease Neuroscience. 52: 1-6. PMID 8433802 DOI: 10.1016/0306-4522(93)90175-F |
0.39 |
|
| 1993 |
Herrero MT, Kastner A, Perez-Otaño I, Hirsch EC, Luquin MR, Javoy-Agid F, Del RÃo J, Obeso JA, Agid Y. Gangliosides and parkinsonism. Neurology. 43: 2132-4. PMID 8413979 DOI: 10.1212/Wnl.43.10.2132 |
0.356 |
|
| 1993 |
Villares J, Faucheux B, Strada O, Hirsch EC, Agid Y. Autoradiographic study of [125Iepidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem Brain Research. 628: 72-76. PMID 8313172 DOI: 10.1016/0006-8993(93)90939-K |
0.394 |
|
| 1993 |
Dürr A, Chneiweiss H, Khati C, Stevanin G, Cancel G, Feingold J, Agid Y, Brice A. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. Brain : a Journal of Neurology. 116: 1497-508. PMID 8293283 DOI: 10.1093/Brain/116.6.1497 |
0.316 |
|
| 1993 |
Kastner A, Hirsch EC, Herrero MT, Javoy‐Agid F, Agid Y. Immunocytochemical Quantification of Tyrosine Hydroxylase at a Cellular Level in the Mesencephalon of Control Subjects and Patients with Parkinson's and Alzheimer's Disease Journal of Neurochemistry. 61: 1024-1034. PMID 8103078 DOI: 10.1111/J.1471-4159.1993.Tb03616.X |
0.404 |
|
| 1993 |
Anglade P, Hirsch EC, Brandel JP, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y. Adrenal transplant, dopaminergic neurons, and Parkinson's disease. Annals of Neurology. 33: 662-3. PMID 8098934 DOI: 10.1002/Ana.410330623 |
0.361 |
|
| 1993 |
Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Research. 606: 341-345. PMID 8098254 DOI: 10.1016/0006-8993(93)91005-D |
0.356 |
|
| 1993 |
Herrero MT, Perez-Otaño I, Oset C, Kastner A, Hirsch EC, Agid Y, Luquin MR, Obeso JA, Del Rio J. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys. Neuroscience. 56: 965-72. PMID 7904332 DOI: 10.1016/0306-4522(93)90142-3 |
0.363 |
|
| 1993 |
Herrero MT, Hirsch EC, Javoy-Agid F, Obeso JA, Agid Y. Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum. Brain Research. 624: 281-5. PMID 7902770 DOI: 10.1016/0006-8993(93)90088-5 |
0.366 |
|
| 1993 |
Blin J, Vidailhet MJ, Pillon B, Dubois B, Feve JR, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 348-54. PMID 1484530 DOI: 10.1002/mds.870070409 |
0.301 |
|
| 1992 |
Dubois B, Pillon B, Agid Y. Deterioration of dopaminergic pathways and alterations in cognition and motor functions. Journal of Neurology. 239. PMID 1634910 DOI: 10.1007/Bf00819560 |
0.373 |
|
| 1992 |
Emre M, Rinne UK, Rascol A, Lees A, Agid Y, Lataste X. Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 7: 239-43. PMID 1535688 DOI: 10.1002/mds.870070309 |
0.37 |
|
| 1992 |
Lange KW, Javoy-Agid F, Agid Y, Jenner P, Marsden CD. Brain muscarinic cholinergic receptors in Huntington's disease. Journal of Neurology. 239: 103-4. PMID 1532417 DOI: 10.1007/Bf00862983 |
0.349 |
|
| 1992 |
Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content? Journal of Neurochemistry. 59: 1080-1089. PMID 1494900 DOI: 10.1111/J.1471-4159.1992.Tb08350.X |
0.36 |
|
| 1992 |
Brice A, Ravisé N, Stevanin G, Gugenheim M, Bouche P, Penet C, Agid Y. Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group. Journal of Medical Genetics. 29: 807-812. PMID 1453432 DOI: 10.1136/Jmg.29.11.807 |
0.307 |
|
| 1992 |
Strada O, Vyas S, Hirsch EC, Ruberg M, Brice A, Agid Y, Javoy-Agid F. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study. Proceedings of the National Academy of Sciences of the United States of America. 89: 9549-9553. PMID 1409664 DOI: 10.1073/Pnas.89.20.9549 |
0.327 |
|
| 1992 |
Ransmayr G, Cervera P, Hirsch EC, Berger W, Fischer W, Agid Y. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology? Neuroscience. 47: 843-851. PMID 1374541 DOI: 10.1016/0306-4522(92)90034-Y |
0.356 |
|
| 1992 |
Michel PP, Agid Y. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures. Brain Research. 597: 233-240. PMID 1361874 DOI: 10.1016/0006-8993(92)91479-X |
0.316 |
|
| 1992 |
Hirsch EC, Mouatt A, Faucheux B, Bonnet AM, Javoy-Agid F, Graybiel AM, Agid Y. Dopamine, tremor, and Parkinson's disease. Lancet (London, England). 340: 125-6. PMID 1352004 DOI: 10.1016/0140-6736(92)90457-E |
0.377 |
|
| 1992 |
Strada O, Hirsch E, Javoy-Agid F, Lehericy S, Ruberg M, Hauw J, Agid Y. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain The Journal of Neuroscience. 12: 4766-4774. DOI: 10.1523/JNEUROSCI.12-12-04766.1992 |
0.39 |
|
| 1992 |
Cervera-Pierot P, Hirsch EC, Javoy-Agid F, Ransmayr G, Hauw JJ, Agid Y. Hippocampal and Parahippocampal Somatostatin 28 and Neuropeptide Y Containing Neurons in Alzheimer's Disease (Part 1 of 2) Dementia and Geriatric Cognitive Disorders. 3: 282-289. DOI: 10.1159/000107028 |
0.354 |
|
| 1991 |
Brandel JP, Hirsch EC, Malessa S, Duyckaerts C, Cervera P, Agid Y. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Neuroscience. 41: 25-31. PMID 2057062 DOI: 10.1016/0306-4522(91)90197-V |
0.322 |
|
| 1991 |
Hirsch EC, Brandel J-, Galle P, Javoy-Agid F, Agid Y. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X-Ray Microanalysis Journal of Neurochemistry. 56: 446-451. PMID 1988548 DOI: 10.1111/J.1471-4159.1991.Tb08170.X |
0.382 |
|
| 1991 |
Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y. Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology. 41: 25-30. PMID 1985290 DOI: 10.1212/Wnl.41.1.25 |
0.312 |
|
| 1991 |
Blin J, Dubois B, Bonnet AM, Vidailhet M, Brandabur M, Agid Y. Does ageing aggravate parkinsonian disability? Journal of Neurology, Neurosurgery, and Psychiatry. 54: 780-2. PMID 1955894 DOI: 10.1136/Jnnp.54.9.780 |
0.353 |
|
| 1991 |
Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y. Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation. Neurology. 41: 1593-7. PMID 1922800 DOI: 10.1212/Wnl.41.10.1593 |
0.338 |
|
| 1991 |
Pillon B, Dubois B, Agid Y. Severity and Specificity of Cognitive Impairment in Alzheimer's, Huntington's, and Parkinson's Diseases and Progressive Supranuclear Palsy Annals of the New York Academy of Sciences. 640: 224-227. PMID 1837977 DOI: 10.1111/J.1749-6632.1991.Tb00222.X |
0.383 |
|
| 1991 |
Holemans S, Javoy F, Agid Y, Laterre E, Maloteaux J. [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy. Brain Research. 565: 154-157. PMID 1837752 DOI: 10.1016/0006-8993(91)91747-O |
0.326 |
|
| 1991 |
Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia Brain. 114: 1953-1975. PMID 1832073 DOI: 10.1093/Brain/114.4.1953 |
0.347 |
|
| 1991 |
Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy Neurology. 41: 634-643. PMID 1827513 DOI: 10.1212/Wnl.41.5.634 |
0.391 |
|
| 1991 |
Lehéricy S, Hirsch EC, Hersh LB, Agid Y. Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients. Neuroscience Letters. 123: 152-5. PMID 1709266 DOI: 10.1016/0304-3940(91)90918-J |
0.334 |
|
| 1991 |
Agid Y. Parkinson's disease: pathophysiology. The Lancet. 337: 1321-1324. PMID 1674304 DOI: 10.1016/0140-6736(91)92989-F |
0.382 |
|
| 1990 |
Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? Annals of Neurology. 27: 676-82. PMID 2360804 DOI: 10.1002/Ana.410270615 |
0.341 |
|
| 1990 |
Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, Agid Y. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Jama Neurology. 47: 747-752. PMID 2357154 DOI: 10.1001/Archneur.1990.00530070035009 |
0.323 |
|
| 1990 |
Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD. Decreased ferritin levels in brain in Parkinson's disease Journal of Neurochemistry. 55: 16-20. PMID 2355217 DOI: 10.1111/J.1471-4159.1990.Tb08814.X |
0.362 |
|
| 1990 |
Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y. Age-induced cognitive disturbances in Parkinson's disease. Neurology. 40: 38-38. PMID 2296380 DOI: 10.1212/Wnl.40.1.38 |
0.342 |
|
| 1990 |
Dubois B, Pillon B, Lhermitte F, Agid Y. Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Annals of Neurology. 28: 117-121. PMID 2221841 DOI: 10.1002/Ana.410280202 |
0.395 |
|
| 1990 |
Chavoix C, Samson Y, Pappata S, Prenant C, Mazière M, Seck A, Agid Y. Positron emission tomography study of brain benzodiazepine receptors in Friedreich's ataxia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 17: 404-9. PMID 2177374 DOI: 10.1017/S0317167100030973 |
0.308 |
|
| 1990 |
Ruberg M, Mayo W, Brice A, Duyckaerts C, Hauw JJ, Simon H, LeMoal M, Agid Y. Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience. 35: 327-33. PMID 2166243 DOI: 10.1016/0306-4522(90)90086-J |
0.386 |
|
| 1990 |
Raisman-Vozari R, Girault JA, Moussaoui S, Feuerstein C, Jenner P, Marsden CD, Agid Y. Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Research. 507: 45-50. PMID 2105823 DOI: 10.1016/0006-8993(90)90520-L |
0.377 |
|
| 1990 |
Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Microtopography of d1 dopaminergic binding sites in the human substantia nigra: An autoradiographic study Neuroscience. 37: 387-398. PMID 1983469 DOI: 10.1016/0306-4522(90)90409-W |
0.315 |
|
| 1990 |
Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience. 38: 245-253. PMID 1979431 DOI: 10.1016/0306-4522(90)90389-L |
0.364 |
|
| 1990 |
Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration. Neurology. 40: 1739-43. PMID 1978260 DOI: 10.1212/Wnl.40.11.1739 |
0.356 |
|
| 1990 |
Vidailhet MJ, Bonnet AM, Belal S, Dubois B, Marle C, Agid Y. Ropinirole without levodopa in Parkinson's disease. Lancet (London, England). 336: 316-7. PMID 1974005 DOI: 10.1016/0140-6736(90)91855-5 |
0.384 |
|
| 1990 |
Dumas S, Javoy‐Agid F, Hirsch E, Agid Y, Mallet J. Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites. Journal of Neuroscience Research. 25: 569-575. PMID 1972200 DOI: 10.1002/Jnr.490250415 |
0.323 |
|
| 1990 |
Ceballos I, Lafon M, Javoy-Agid F, Hirsch E, Nicole A, Sinet PM, Agid Y. Superoxide dismutase and Parkinson's disease. Lancet. 335: 1035-6. PMID 1970085 DOI: 10.1016/0140-6736(90)91099-V |
0.375 |
|
| 1989 |
Girault JA, Raisman-Vozari R, Agid Y, Greengard P. Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proceedings of the National Academy of Sciences of the United States of America. 86: 2493-7. PMID 2928345 DOI: 10.1073/PNAS.86.7.2493 |
0.426 |
|
| 1989 |
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease Journal of Neurochemistry. 52: 381-389. PMID 2911023 DOI: 10.1111/J.1471-4159.1989.Tb09133.X |
0.334 |
|
| 1989 |
Scherman D, Desnos C, Darchen F, Pollak P, Agid Y. Striatal dopamine deficiency in parkinson's disease: Role of aging Annals of Neurology. 26: 551-557. PMID 2817829 DOI: 10.1002/Ana.410260409 |
0.38 |
|
| 1989 |
Pourcher E, Bonnet A, Kefalos J, Dubois B, Agid Y. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease. Movement Disorders. 4: 195-201. PMID 2779590 DOI: 10.1002/Mds.870040301 |
0.319 |
|
| 1989 |
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease Journal of Neurochemistry. 52: 1830-1836. PMID 2723638 DOI: 10.1111/J.1471-4159.1989.Tb07264.X |
0.34 |
|
| 1989 |
Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? Journal of Neurology, Neurosurgery, and Psychiatry. 52: 201-206. PMID 2703838 DOI: 10.1136/Jnnp.52.2.201 |
0.39 |
|
| 1989 |
Lehéricy S, Hirsch EC, Cervera P, Hersh LB, Hauw JJ, Ruberg M, Agid Y. Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 86: 8580-4. PMID 2682652 DOI: 10.1073/Pnas.86.21.8580 |
0.38 |
|
| 1989 |
Ransmayr G, Cervera P, Hirsch E, Ruberg M, Hersh LB, Duyckaerts C, Hauw J-, Delumeau C, Agid Y. Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience. 32: 701-714. PMID 2601840 DOI: 10.1016/0306-4522(89)90291-1 |
0.304 |
|
| 1989 |
Blin J, Baron JC, Cambon H, Bonnet AM, Dubois B, Loc'h C, Mazière B, Agid Y. Striatal dopamine D2 receptors in tardive dyskinesia: PET study. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 1248-1252. PMID 2574230 DOI: 10.1136/Jnnp.52.11.1248 |
0.3 |
|
| 1989 |
Temlett JA, Quinn NP, Jenner PG, Marsden CD, Pourcher E, Bonnet AM, Agid Y, Markstein R, Lataste X. Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 261-5. PMID 2571082 DOI: 10.1002/mds.870040307 |
0.391 |
|
| 1989 |
Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raisman R, Ruberg M. Biochemistry of Parkinson's disease 28 years later: a critical review. Movement Disorders : Official Journal of the Movement Disorder Society. S126-44. PMID 2566912 DOI: 10.1002/mds.870040514 |
0.346 |
|
| 1989 |
Hirsch EC, Graybiel AM, Hersh LB, Duyckaerts C, Agid Y. Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum. Neuroscience Letters. 96: 145-50. PMID 2522606 DOI: 10.1016/0304-3940(89)90048-7 |
0.307 |
|
| 1989 |
Javoyagid F, Scatton B, Ruberg M, Lheureux R, Cervera P, Raisman R, Maloteaux J, Beck H, Agid Y. Distribution of Monoaminergic, Cholinergic, and Gabaergic Markers in the Human Cerebral-cortex Neuroscience. 29: 251-259. PMID 2471113 DOI: 10.1016/0306-4522(89)90055-9 |
0.32 |
|
| 1988 |
Blin J, Bonnet A, Agid Y. Does levodopa aggravate Parkinson's disease? Neurology. 38: 1410-1410. PMID 3412589 DOI: 10.1212/Wnl.38.9.1410 |
0.409 |
|
| 1988 |
Hirsch E, Ruberg M, Portier M, Dardenne M, Agid Y. Characterization of two antigens in parkinsonian Lewy bodies. Brain Research. 441: 139-144. PMID 3359227 DOI: 10.1016/0006-8993(88)91391-1 |
0.379 |
|
| 1988 |
Maloteaux J, Vanisberg MA, Laterre C, Javoy-Agid F, Agid Y, Laduron PM. [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. European Journal of Pharmacology. 156: 331-340. PMID 3215281 DOI: 10.1016/0014-2999(88)90278-6 |
0.309 |
|
| 1988 |
Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of Cognitive Processing in Progressive Supranuclear Palsy: A Comparison With Parkinson's Disease Jama Neurology. 45: 1194-1199. PMID 3190499 DOI: 10.1001/Archneur.1988.00520350032011 |
0.365 |
|
| 1988 |
Maloteaux JM, Luabeya MAK, Vanisberg MA, Christian Laterre E, Laduron PM, Javoy-Agid F, Agid Y. Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy Brain Research. 446: 321-332. PMID 2836033 DOI: 10.1016/0006-8993(88)90891-8 |
0.381 |
|
| 1988 |
Taquet H, Nomoto M, Rose S, Jenner P, Javoy-Agid F, Mauborgne A, Benoliel JJ, Marsden CD, Legrand JC, Agid Y, Hamon M, Cesselin F. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment. Neuropeptides. 12: 105-110. PMID 2468106 DOI: 10.1016/0143-4179(88)90039-X |
0.365 |
|
| 1987 |
Dubois B, Danzé F, Pillon B, Cusimano G, Lhermitte F, Agid Y. Cholinergic‐dependent cognitive deficits in Parkinson's disease Annals of Neurology. 22: 26-30. PMID 3631918 DOI: 10.1002/Ana.410220108 |
0.323 |
|
| 1987 |
Bonnet A-, Loria Y, Saint-Hilaire M-, Lhermitte F, Agid Y. Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 37: 1539-1539. PMID 3627454 DOI: 10.1212/Wnl.37.9.1539 |
0.409 |
|
| 1987 |
Bonnet AM, Tell G, Schechter PJ, Grove J, Saint‐Hilaire MH, Smet YD, Agid Y. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea. Movement Disorders. 2: 117-123. PMID 2973560 DOI: 10.1002/Mds.870020206 |
0.329 |
|
| 1987 |
Ruberg M, Villageois A, Bonnet AM, Pillon B, Rieger F, Agid Y. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. Journal of Neurology, Neurosurgery, and Psychiatry. 50: 538-543. PMID 2953866 DOI: 10.1136/Jnnp.50.5.538 |
0.323 |
|
| 1987 |
Taquet H, Javoy-Agid F, Mauborgne A, Benoliel JJ, Agid Y, Legrand JC, Hamon M, Cesselin F. Brain neuropeptides in progressive supranuclear palsy. Brain Research. 411: 178-182. PMID 2440513 DOI: 10.1016/0006-8993(87)90697-4 |
0.412 |
|
| 1986 |
Ruberg M, Rieger F, Villageois A, Bonnet AM, Agid Y. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease Brain Research. 362: 83-91. PMID 3942870 DOI: 10.1016/0006-8993(86)91401-0 |
0.346 |
|
| 1986 |
Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease Neurology. 36: 1179-1179. PMID 3748383 DOI: 10.1212/Wnl.36.9.1179 |
0.384 |
|
| 1986 |
Dubois B, Pillon B, Saxce HD, Lhermitte F, Agid Y. Disappearance of Parkinsonian signs after spontaneous vascular ``thalamotomy'' Jama Neurology. 43: 815-817. PMID 3729763 DOI: 10.1001/Archneur.1986.00520080057021 |
0.363 |
|
| 1986 |
Baron JC, Mazière B, Loc'h C, Cambon H, Sgouropoulos P, Bonnet AM, Agid Y. Loss of Striatal [76Br]Bromospiperone Binding Sites Demonstrated by Positron Tomography in Progressive Supranuclear Palsy Journal of Cerebral Blood Flow and Metabolism. 6: 131-136. PMID 3485639 DOI: 10.1038/Jcbfm.1986.26 |
0.329 |
|
| 1986 |
Agid Y, Taquet H, Cesselin F, Epelbaum J, Javoy-Agid F. Neuropeptides and parkinson's disease Progress in Brain Research. 66: 107-116. PMID 2431436 DOI: 10.1016/S0079-6123(08)64600-2 |
0.357 |
|
| 1986 |
Jenner P, Taquet H, Mauborgne A, Benoliel JT, Cesselin F, Rose S, Javoy-Agid F, Agid Y, Marsden CD. Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset. Journal of Neurochemistry. 47: 1548-51. PMID 2428937 DOI: 10.1111/J.1471-4159.1986.Tb00793.X |
0.341 |
|
| 1986 |
Agid Y, Ruberg M, Dubois B, Pillon B, Cusimano G, Raisman R, Cash R, Lhermitte F. Parkinsonʼs Disease and Dementia Clinical Neuropharmacology. 9. DOI: 10.1097/00002826-198600092-00004 |
0.303 |
|
| 1985 |
Jegou S, Javoy-Agid F, Delbende C, Ruberg M, Vaudry H, Agid Y. Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 48: 842-843. PMID 4031938 DOI: 10.1136/Jnnp.48.8.842 |
0.315 |
|
| 1985 |
Dubois B, Mayo W, Agid Y, Moal ML, Simon H. Profound disturbances of spontaneous and learned behaviors following lesions of the nucleus basalis magnocellularis in the rat. Brain Research. 338: 249-258. PMID 4027594 DOI: 10.1016/0006-8993(85)90154-4 |
0.331 |
|
| 1985 |
Monfort JC, Javoy-Agid F, Hauw JJ, Dubois B, Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain. 108: 301-313. PMID 4005526 DOI: 10.1093/Brain/108.2.301 |
0.375 |
|
| 1985 |
Bissette G, Nemeroff CB, Decker MW, Kizer JS, Agid Y, Javoy-Agid F. Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease. Annals of Neurology. 17: 324-8. PMID 4004152 DOI: 10.1002/ana.410170403 |
0.395 |
|
| 1985 |
D'antona R, Baron JC, Samson Y, Serdaru M, Viader F, Agid Y, Cambier J. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy Brain. 108: 785-799. PMID 3876136 DOI: 10.1093/Brain/108.3.785 |
0.302 |
|
| 1985 |
Cash R, Lasbennes F, Sercombe R, Seylaz J, Agid Y. Adrenergic receptors on cerebral microvessels in control and Parkinsonian subjects Life Sciences. 37: 531-536. PMID 2991685 DOI: 10.1016/0024-3205(85)90465-5 |
0.307 |
|
| 1985 |
Taquet H, Javoy-Agid F, Giraud P, Legrand JC, Agid Y, Cesselin F. Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain. Brain Research. 341: 390-392. PMID 2864101 DOI: 10.1016/0006-8993(85)91081-9 |
0.308 |
|
| 1984 |
Rougemont D, Baron JC, Collard P, Bustany P, Comar D, Agid Y. Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 47: 824-830. PMID 6332176 DOI: 10.1136/Jnnp.47.8.824 |
0.362 |
|
| 1984 |
Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y. Biochemistry of the hypothalamus in Parkinson's disease Neurology. 34: 672-672. PMID 6143285 DOI: 10.1212/Wnl.34.5.672 |
0.385 |
|
| 1984 |
Llorens-Cortes C, Javoy-Agid F, Agid Y, Taquet H, Schwartz JC. Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects. Journal of Neurochemistry. 43: 874-7. PMID 6086841 DOI: 10.1111/j.1471-4159.1984.tb12812.x |
0.313 |
|
| 1984 |
Hurtig H, Fisher C, Ringwald E, Ruberg M, Javoy-Agid F, Agid Y. WHAT CAUSES PARKINSON'S DISEASE? The Lancet. 323: 336-337. DOI: 10.1016/S0140-6736(84)90379-9 |
0.381 |
|
| 1983 |
Pimoule C, Schoemaker H, Javoy-Agid F, Scatton B, Agid Y, Langer SZ. Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease. European Journal of Pharmacology. 95: 145-6. PMID 6667712 DOI: 10.1016/0014-2999(83)90281-9 |
0.302 |
|
| 1983 |
Dunois B, Ruberg M, Ploska A, Agid Y. A subcortico-cortical cholinergic system is affected in Parkinson's disease Brain Research. 288: 213-218. PMID 6661617 DOI: 10.1016/0006-8993(83)90096-3 |
0.333 |
|
| 1983 |
Taquet H, Javoy-Agid F, Hamon M, Legrand JC, Agid Y, Cesselin F. Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain. Brain Research. 280: 379-382. PMID 6652499 DOI: 10.1016/0006-8993(83)90071-9 |
0.328 |
|
| 1983 |
Scatton B, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Research. 275: 321-328. PMID 6626985 DOI: 10.1016/0006-8993(83)90993-9 |
0.348 |
|
| 1983 |
Javoy-Agid F, Grouselle D, Tixier-Vidal A, Agid Y. Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease Neuropeptides. 3: 405-410. PMID 6413883 DOI: 10.1016/0143-4179(83)90029-X |
0.339 |
|
| 1983 |
Mauborgne A, Javoy-Agid F, Legrand JC, Agid Y, Cesselin F. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Research. 268: 167-170. PMID 6190539 DOI: 10.1016/0006-8993(83)90403-1 |
0.357 |
|
| 1983 |
Epelbaum J, Ruberg M, Moyse E, Dubois B, Agid Y. Somatostatin and dementia in Parkinson's disease. Brain Research. 278: 376-379. PMID 6139152 DOI: 10.1016/0006-8993(83)90277-9 |
0.36 |
|
| 1983 |
Gaspar P, Berger B, Hamon M, Cesselin F, Vigny A, Javoy-Agid F, Agid Y. Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships. Journal of the Neurological Sciences. 58: 247-267. PMID 6131945 DOI: 10.1016/0022-510X(83)90221-6 |
0.33 |
|
| 1983 |
Perry TL, Javoy-Agid F, Agid Y, Fibiger HC. Striatal GABAergic neuronal activity is not reduced in Parkinson's disease. Journal of Neurochemistry. 40: 1120-3. PMID 6131932 DOI: 10.1111/J.1471-4159.1983.Tb08102.X |
0.375 |
|
| 1983 |
Garbarg M, Javoy-Agid F, Schwartz JC, Agid Y. Brain Histidine Decarboxylase Activity In Parkinson'S Disease The Lancet. 321: 74-75. PMID 6129410 DOI: 10.1016/S0140-6736(83)91613-6 |
0.367 |
|
| 1982 |
Scatton B, Rouquier L, Javoy-Agid F, Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson disease Neurology. 32: 1039-1039. PMID 7202156 DOI: 10.1212/Wnl.32.9.1039 |
0.353 |
|
| 1982 |
Taquet H, Javoy-Agid F, Cesselin F, Hamon M, Legrand JC, Agid Y. Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains Brain Research. 235: 303-314. PMID 7188329 DOI: 10.1016/0006-8993(82)91009-5 |
0.331 |
|
| 1982 |
Smet Yd, Ruberg M, Serdaru M, Dubois B, Lhermitte F, Agid Y. Confusion, dementia and anticholinergics in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 45: 1161-1164. PMID 7161613 DOI: 10.1136/Jnnp.45.12.1161 |
0.354 |
|
| 1982 |
Ploska A, Taquet H, Javoy-Agid F, Gaspar P, Cesselin F, Berger B, Hamon M, Legrand JC, Agid Y. Dopamine and methionine-enkephalin in human brain Neuroscience Letters. 33: 191-196. PMID 7155460 DOI: 10.1016/0304-3940(82)90250-6 |
0.343 |
|
| 1982 |
Ruberg M, Ploska A, Agid Y. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Research. 232: 129-139. PMID 7055689 DOI: 10.1016/0006-8993(82)90615-1 |
0.327 |
|
| 1982 |
Studler JM, Javoy-Agid F, Cesselin F, Legrand JC, Agid Y. CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients Brain Research. 243: 176-179. PMID 6288173 DOI: 10.1016/0006-8993(82)91135-0 |
0.397 |
|
| 1981 |
Quinn N, Illas A, Lhermitte F, Agid Y. Bromocriptine in Parkinson's disease: A study of cardiovascular effects Journal of Neurology Neurosurgery and Psychiatry. 44: 426-429. PMID 7264689 DOI: 10.1136/Jnnp.44.5.426 |
0.303 |
|
| 1981 |
Javoy‐Agid F, Taquet H, Ploska A, Cherif‐Zahar C, Ruberg M, Agid Y. Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease. Journal of Neurochemistry. 36: 2101-2105. PMID 7241152 DOI: 10.1111/J.1471-4159.1981.Tb10843.X |
0.378 |
|
| 1981 |
Quinn N, Illas A, Lhermitte F, Agid Y. Bromocriptine and domperidone in the treatment of parkinson disease Neurology. 31: 662-667. PMID 7195483 DOI: 10.1212/Wnl.31.6.662 |
0.328 |
|
| 1981 |
Taquet H, Javoy-Agid F, Cesselin F, Agid Y. Methionine-enkephalin deficiency in brains of patients with Parkinson's disease. The Lancet. 317: 1367-1368. PMID 6113335 DOI: 10.1016/S0140-6736(81)92543-5 |
0.395 |
|
| 1980 |
Gaspar P, Javoy‐Agid F, Ploska A, Agid Y. Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain Journal of Neurochemistry. 34: 278-283. PMID 6106047 DOI: 10.1111/J.1471-4159.1980.Tb06593.X |
0.311 |
|
| 1979 |
Agid Y, Bonnet AM, Pollak P, Signoret JL, Lhermitte F. BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING AGENT IN TREATMENT OF PARKINSON'S DISEASE The Lancet. 313: 570-572. PMID 85162 DOI: 10.1016/S0140-6736(79)91003-1 |
0.341 |
|
| 1977 |
Javoy F, Euvrard C, Herbet A, Bockaert J, Enjalbert A, Agid Y, Glowinski J. Lack of involvement of dopaminergic and GABA neurones in the inhibitory effect of harmaline on the activity of striatal cholinergic neurones in the rat Naunyn-Schmiedebergs Archives of Pharmacology. 297: 233-239. PMID 141623 DOI: 10.1007/Bf00509266 |
0.305 |
|
| 1973 |
Sotelo C, Agid Y, Glowinski J. Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. Brain Research. 58: 269-290. PMID 4756130 DOI: 10.1016/0006-8993(73)90001-2 |
0.303 |
|
| Show low-probability matches. |